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Bacterial biofilms cause severe infections in clinial fields and contamination 
problems in environmental facilities. Due to the uniq e complex structure of biofilms that 
comprise diverse polysaccharides and bacteria, traditional antibiotic therapies require a 
thousand times higher concentration compared to non-bi film associated infections. The 
early detection of biofilms, before their structures are fully established in a given 
host/environment, is critical in order to eradicate th m effectively. Also, the development 
of a new innovative biofilm treatment method that cn be utilized with a low dose of 
antibiotic would be extremely important to the medical community.  
In this dissertation, a biofilm sensor and a new biofilm treatment method were 
independently developed to detect and treat biofilm communities, respectively. 
Furthermore, an integrated microsystem was demonstrated as a single platform of the 
sensor with the treatment method.  
The sensor was based on the surface acoustic wave (SAW) detection mechanism, 
which is an extremely sensitive for biofilm monitorng (hundreds of bacterial population 
detection limit) and consumes very low power (~100 µW). A piezoelectric ZnO layer 
fabricated by a pulsed laser deposition process wasa key material to induce 
homogeneous acoustic waves. Reliable operation of the sensor was achieved using an 
Al 2O3 film as a passivation layer over the sensor to protect ZnO degradation from the 
growth media.  The sensor successfully demonstrated real-time monitoring of biofilm 
growth.  
The new biofilm treatment was developed based on the principles of the 
bioelectric effect that introduces an electric field along with antibiotics to biofilms, 
demonstrating significant biofilm inhibition compared to antibiotic treatment alone. 
Specifically, the new bioelectric effect was implementedwith a superpositioned (SP) 
electric field of both alternating and direct current (AC and DC) and the antibiotic 
gentamicin (10 µg/mL). With the SP field treatment, significant biofilm reduction was 
demonstrated in total biomass (~ 71 %) as well as vible bacterial density (~ 400 times 
respected to the only antibiotic therapy) of the tra ed biofilms. This method was 
transferred to a microfluidic system using microfabricated planar electrodes. The 
microsystem-level implementation of the bioelectric effect also showed enhanced biofilm 
reduction (~ 140 % total biomass reduction improvement). The integrated system was 
based on the SAW sensor with the addition of coplanar thin electrodes to apply electric 
signals for the biofilm treatment. 
The chip was tested with two bacterial biofilms (Escherichia coli and 
Pseudomonas aeruginosa) that are clinically relevant strains. In both biofilm experiments, 
the integrated system demonstrated successful real-time biofilm monitoring and effective 
biofilm inhibition. This systematic integration of a continuous monitoring method with a 
novel effective treatment technique has advanced th s ate of the art in the field of 
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Chapter 1: Introduction  
 
1.1 Background and Motivation 
The number of medical devices for health care is expected to increase significantly 
over the next decades due to the increase in life exp ctancy resulting from biomedical 
technology advances. Medical deviceapplications include artificial joints, heart valves, 
and catheters as shown in figure 1.13. One of the problems associated with medical 
implants is severe infection due to bacterial biofilms. Theseare complex communities of 
groups of bacteria with diverse extracellular materi ls. Once biofilms are established, 
traditional antibiotic treatments are often ineffective since biofilms are characterized by 
high antibiotic resistance and require significantly higher doses of drugs due to the 
extracellular matrix2. Thus, the early detection of biofilms is critical for effective 
management. Current diagnostic methods (i.e. blood tests, radiographic exams, multi-site 
biopsies, and cell culture) are not specific for detection of biofilms1, 2 as well as selected 
time-point measurements. These methods often require external instruments, making in-
patient treatment necessary and inconvenient for the patients. Furthermore, when biofilms 
are formed on the implants, the most effective way of biofilm treatment is surgery to 
remove the infected-implants. The treatments usually involve intravenous antibiotic 
administrationand replacement surgery, 4. Revisional surgery and care can cost over 
$500,000 per patient, amounting to more than $2 billion annually in the United States1. 
Therefore, developing a biomedical system that enabl s not only biofilm growth 
monitoring, but also its treatment3, is desirable for clinical applications. 
Biofilms are not simply a group of bacteria, but complex communities. Bacteria can 
adhere to surfaces, and by dividing, increase their population to form microcolonies5. 
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(b) (c) (a) 
When bacteria reach population threshold, they produce and secret cell communicating 
molecules, such as autoinducer-2 (AI-2), resulting in formation of extracellular matrix 
and toxins throughout the bacterial quorum sensing3. Figure 1.2 shows a summarized 













Figure.1.1: Examples of medical implants, (a) artificial heart valve (ADAM Inc.), (b) 
catheter (NSC Inc.), and (c) artificial hip joint (Zimmer Inc.) 
 
 
Bacteria in biofilms can exchange genes, forming a heterogeneous bacterial composition 
which induces  more resistance to antimicrobial agents than suspended bacteria6, 7. The 
extracellular matrix is composed of diverse polysacch rides and proteins, among other 
biological molecules8. The matrix maintains the mechanical structure of the biofilm and 
its physiological function as a protective layer against diffusion of antibiotics and 
recognition by the immune system6. Due to the complex structure and heterogeneous 
bacterial composition, not only can antibiotics notdiffuse into biofilm, but biofilms also 
show high antibiotic resistance. As a result, the biofilms are much less susceptible to 




(1) (2) (3) (4) 
Figure 1.2: Schematic of biofilm growth progression3. (1) planktonic bacteria adhere on a 
surface, (2) form a monolayer of bacteria, (3) increase their population resulting in 









This fact is supported by studies indicating thatantibiotic concentration 500 – 5000 times 
higher is required to treat a biofilm as compared to a bacterial suspension9.  
Therefore, an early detection of biofilm is of great interest to alert the presence of the 
bacterial biofilms before establishing their structures. Furthermore, developing an 
alternative biofilm treatment utilizing low doses of antibiotics that cannot cause severe 
side effects due to the high concentration of drugs10 i  desired to reduce biofilms 
effectively andavoid invasive treatments.  
 
 
1.2   Microsystems for Biological Applications 
 
A microsystem in the form of a biomedical device has advantages for both in-vitro 
and in-vivo applications based on small dimensions, low electric power consumption, 
portability and small volume requirements of the system. A number of microscale 
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devices have been demonstrated for chemical and biological applications, such as 
personal medicine11 and diagnostic methods12. 
Microsystems typically require micro/nano-liter volumes of the sample for analysis 
that is extremely small compared to the traditional m cro-scale experimental setup13. Due 
to the low volume requirement, a high throughput microsystem is desired particularly 
when samples are limited. Lab-on-a-chip devices are examples of microsystemss for 
biological and clinical applications, such as sample preparation14, biomolecular sensing15 
and platforms for drug discovery research13. These systems demonstrated high sensitivity 
and low detection limit16 compared to traditional macro-scale setups due to the precise 
experimental condition control based on the unique physics of the microscale such as 
laminar flow9.  
In addition, an implantable microdevice has been demonstrated for in-vivo 
applications. Considering the challenges of implantable devices, microsystems have 
unique advantages. First of all, the materials used in typical microsystems, such as inert 
metals and silicon, can be fully biocompatible17. The size of the microscale device also is 
typically small enough to be implanted in the body18. Due to the low power consumption 
of the system (less than micro-watt19), the entire device can be designed as a passive 
system which does not require a battery to operateperiodically20 . Finally, a high 
sensitivity of the microsensor allows for reliable operation of the device in an in-vivo 
environment21 . Microfabrication technologies enable designing and producing of 
sophisticated structures, devices, and systems on the scale of micrometers with 




Highly sensitive biocompatible devices based on fabric tion technologies have been 
demonstrated for biomedical applications, such as glucose sensors, blood pressure 
sensors, and explosive gas sensors22. An implantable blood pressure sensor as shown in 
figure 1.3 (a), has been applied for real-time monitoring of blood pressure for heart 
failure patients23 . The capability of integration with other systems (i.e. wireless 
communication, CMOS electronics, microfluidic devices and energy storage systems) in 
a micro-scale device provides a unique advantage for real-time monitoring24 . For 
example, a wireless and non-invasive glucose sensor for diabetes patients has been 
developed by integrating the sensor with a radio frequency (RF) circuit and antenna as 






Figure 1.3: Examples of the implantable devices. (a) an implantable blood pressure 
sensor for heart failure patients(www.cardioMEMS.com), (b) schematic of an implantable 
glucose sensor for diabetes patients (www.cybersensors.com). 
The robustness of fabrication technologies with biocompatible materials also allows 
development of a complex system which can be used in a harsh environment, such as 
space environments26.  
Based on these advantages of microfabricated devices, d velopment of a 




biofilm associated infection challenges in biomedical fields including clinical and 
environmental applications, such as biofilm infections27 and water contamination due to 




1.3    Summary of Thesis Accomplishments and Impact 
 
This thesis work accomplished (1) design, fabrication and test of a biofilm sensor, 
(2) development a new effective biofilm treatment with low doses of antibiotics and (3) 
integration of the sensor with the effective treatment as an integrated microsystem. The 
sensor successfully monitored biofilm growth in real-time and was reusable based on a 
novel passivation film. The newly developed biofilm treatment method was utilized by 
combining a low intensity of electric field with antibiotics based on the principles of the 
bioelectric effect. Reduction of biofilm treated by the new method demonstrated 
significant enhancement of biofilm treatment compared to traditional antibiotic therapies. 
Finally, the integrated microsystem was successfully designed, fabricated and 
demonstrated continuous biofilm growth monitoring as well as effective biofilm 
inhibition. The integration of biofilm detection and treatment on a single chip was critical 
to alert presence of biofilms at the early stage of their growth as well as achieve an 
alternative treatment method instead of massive antibiotic therapies. Since the system 
consumes low electric power and has small dimensions with biocompatible materials, it 
can potentially be applied for both in-vitro and in-vivo biofilm management, such as on 
water pipe biofilm growth monitoring and on the surface of implants where there are high 
risks of biofilm-associated infections. The implanted system especially would improve 
patient care through the early detection of biofilms and the potential prevention of 





1.3.1    Design and Fabrication of a Biofilm Sensor 
When biofilms are established, it is extremely difficult to eradicate them without 
using significantly higher doses of antibiotics or invasive surgeries1-3, 6. Moreover, since 
biofilms can be established within 10 – 20 hours from initial infection, real-time 
monitoring of biofilms is desirable for clinical applications compared to end-point 
evaluation. Therefore, continuous monitoring of biofilms is critical. The sensing of 
biofilm in this thesis work was achieved by a Surface Acoustic Wave (SAW) sensor 
considering its advantages such as low electric power requirement, high sensitivity and 
biocompatibility29. In the design of the sensor, a passivation film to achieve reliable 
operationin both bacterial growth media and animal serum was investigated theoretically 
with supporting experiments30. The operation frequency of the sensor was designed based 
on the regulation from the Federal Communication Commission for future implantable 
applications. High quality crystalline zinc oxide (ZnO) to achieve high sensitivitywas 
used as the piezoelectric material. Due to the effectiv  passivation and high quality ZnO, 
the sensor was reusable in consecutive experiments and demonstrated sensitive biofilm 
detection. The SAW sensor has also shown successful real-time growth monitoring of 
biofilms in an animal serum27.  
 
1.3.2   Development of an Effective Biofilm Treatment 
The concentration of antibiotic to treat biofilms is 500 – 5000 times more than 
that in planktonic bacteria6 which requires invasive surgery to treat biofilms. Such high 
doses of antibiotics typically induce severe side-eff cts. Thus, development of an 
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alternative treatment utilized by low doses of drug is essential to manage biofilm 
infections effectively. The enhanced treatment of biofilms can be implemented by 
imposing electric fields with antibiotics simultaneously known as the bioelectric effect. In 
literature, electric fields typically applied either only direct or alternative current (DC or 
AC) for the bioelectric effect. In this thesis work, the combination of DC and AC fields 
was used for the first time as a superpositioned bioelectric effect and showed significant 
improvement of biofilm reduction compared to the traditional antibiotic method31. Due to 
the strong improvement of the efficacy, concentration of antibiotics was only required 2-
3 times of the dose for planktonic bacterial infection. In addition, since the intensity of 
the field was even less than the electrolysis threshold voltage of biological fluid, the 
electric field caused minimized media decomposition which was critical to apply the 
method for clinical biofilm treatment. The development was completed in a macro-scale 
traditional cuvette setup29 and evaluated by microbiological methods including live cell 
culture and total biomass quantification.  
 
1.3.3 Demonstration of the Treatment in a Microfluidic System 
Based on the new biofilm treatment method demonstrated in a macro-scale 
setup29, the superpositioned bioelectric effect (SP-BE) was further developed using a 
planar electrode on a microfluidic platform32. Scaling of the SP-BE to the micro-scale is a 
critical requirement for realizing clinical applications of the method due to the required 
small dimension of the system, such as for in vivo biofilm treatment. The microfluidic 
device was chosen for on-chip SP-BE demonstration based on the advantages of high 
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experimental throughput, decreased volume requirements, and precise environmental 
control within microfluidic growth environments33. The voltage requirement of the SP 
field in the microfluidic platform (0.25 V) was further reduced below the electrolysis 
potential of the media (0.82 V at pH 7 with 25 °C) by decreasing the electrode spacing 
distance (2 mm) compared to the conventional macro-scale cuvette seup (4 mm). Planar 
thin film electrodes (200 nm thickness gold) were utilized to induce the electric field in a 
microfluidic growth reactor. Detection of biofilm growth and treatment within the 
platform is achieved via the in situ measurement of biofilm optical density (OD), where 
the use of linearly arrayed photopixels enables spatiotemporal biofilm monitoring within 
the microchannel. Using the platform, the SP-BE demonstrated significantly improved 
biofilm treatment efficacy30. 
 
 
1.3.4 Systematic Integration of the Biofilm Sensor with the Treatment 
Based on the demonstration of the SAW sensor for bifilm detection and the 
superpositioned bioelectric effect for biofilm reduction  in a microfluidic platform, an 
integrated microsystem was designed, fabricated and tested as biofilms were established 
and treated on the chips. This integration of the sensor with the treatment was designed as 
a feedback system. At first, the sensing component of the system provides total amount of 
the biofilms. Based on the stage of their growth, the treatment part of integrated chip can 
trigger the effective biofilm reduction by simultaneously monitoring changes in biomass 
by the SAW sensor component. Due to the bi-directional communication realized through 
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the integration, a systematic and effective biofilm anagement for clinical and 
environmental applications is demonstrated  compared to the traditional end-pointbiofilm 
measurements either only detection or treatment. The chip was successfully 
microfabricated and demonstrated its biofilm detection as well as treatment monitoring 







Figure 1.4: Concept of systematic biofilm management. By integrating a biofilm sensor 
with a treatment method as a microsystem, an effective biofilm infectious disease 






Biofilm Sensing Feedback 





1.4   Literature Review 
1.4.1 Macroscale Systems for Biofilms 
The system developed in this work for the growth, treatment, and monitoring of 
bacterial biofilms represents a new method of conducting studies related to bacteria and 
their infections, including those studies aimed at drug screening and development. 
Currently, the majority of drug screening methods utilize macroscale devices and systems 
to perform assays that determine the effectiveness of prospective treatments on inhibiting 
or eradicating microbial growths. Advanced industry methods utilize primarily automated 
systems to perform common screening techniques, such as broth microdilution, antibiotic 
gradient, and disk diffusion studies on mature microbial cultures to determine the 
efficacy of various treatments as well as the minimal inhibitory concentration (MIC) of 
these drugs (Figure 1.5 and 1.6)33.   
 
 
Figure 1.5: A broth microdilution susceptibility panel (microtiter plate) containing 98 
reagent wells and a disposable tray inoculator35. Bacteria samples in suspension are 
treated with various concentrations of candidate drugs and each suspension tested using 




Figure 1.6: A colony forming unit (CFU) assay for evaluation of antibiotic biocidal effect 
in various concentration treatment. The number of CFU corresponds to the viable cell 
population in each treatment.  
 
In addition to these microbiological methods, other immunoassays are frequently used to 
perform highly selective and sensitive studies by integrating methods such as ELISA, 
fluoroimmunoassay (FIA) and time-resolved fluoroimmunoassay (TRFIA) with large-
scale capabilities, however, these methods are also limited in the types of molecules they 
can detect and therefore are not currently an all-encompassing method for antimicrobial 
drug screening.   
  The majority of previous biofilm studies have utilized macroscale methods to 
determine biofilm viability, biomass, and overall structure for various biomedical, 
industrial, and environmental applications. The majority of these studies were performed 
14 
 
using macroscale flow reactors to culture biofilm samples with integrated, external 
detection methods.   
One of the most basic methods of biofilm quantification involves the counting of 
bacterial colonies, where bacteria are cultured on an agar plate and subsequently 
enumerated using microscopy and image analysis to determine their average density36.  
Polymerase chain reaction (PCR) techniques are another s andard method, which uses the 
amplification of DNA segments to quantify the presenc  of target biological elements37. 
Fluorescence techniques provide an extremely accurate and simple method of biofilm 
detection by applying a fluorescent stain to a sample or, for greater precision, genetically 
engineering bacteria strains to selectively express a fluorescent protein38.  Heyduk, et al.39 
demonstrated a representative fluorescent immunosens r technique shown in Figure 1.7, 
in which nanometer scale linkers modified with fluorochromes could participate in 










Similar to the FRET approach, considerable research has been directed towards the 
use of the Enzyme-Linked Immunosorbent Assay (ELISA) in laboratories to perform 
detection analyses on mixed cultures40.  ELISA utilizes the specific binding of particular 
antibodies and antigens in combination with a fluorescent label to enable a specific and 
highly sensitive method for quantitative measurement of target antibodies or analytes in 
solution.  The method has seen vast use as a diagnostic t ol in medical and other 
industrial fields and is also useful for chemical quality assurance due to its high 
sensitivity and selectivity.  A typical procedure for performing an ELISA analysis in a 
laboratory setting is provided in Figure 1.8 below.   
 
 
Figure 1.8: Typical ELISA 
antibody (2) as sample is added any matching antigen is captured by the antibody (3) a 
suitable biotin labeled detection antibody binds to the antigen (4) a second conjugate 




Despite the highly selective and precise results provided by ELISA, it is rather arduous to 
perform, often requiring up to a full week for analysis, and often difficult to perform 
lab-on-a-chip devices.  As a result, it has limited usefulness for high
screening applications, lending to the development of new techniques for biofilm 
detection.   
However, since this and similar approaches require a labeling method an
microscopy equipment such as a confocal or fluorescence microscope for biofilm 
detection, it does not represent a high throughput or cost effective method of sensing, 
thus presenting a barrier to drug screening applications. Moving forward, new 
drug screening must utilize emerging technologies, such as the micro/nano methods 
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procedure: (1) A plate is coated with a suitable capture 









presented previously in order to take advantage of the benefits provided by devices at this 
scale.   
1.4.2   Micro-Systems for Biofilms 
Microsystems have significant advantages especially for bacterial biofilm studies 
due to the low sample volume requirement, high throughput system, and integration with 
other modules including sensing of biofilms. Microscale methods leverage the 
technologies available for larger systems while taking advantage of capabilities only 
available in microscale and microfabricated devices.  Some of these methods enable on-
chip biofilm detection that is not possible in macroscale systems, while others adapt 
existing macroscale technologies to smaller environme ts.  By adapting macroscale 
technologies to microscale regimes, key advantages of micro/nano detection are 
leveraged including the use of small sample sizes, highly parallel throughput, tight 
control over environmental conditions, and inexpensive production through batch 
fabrication.   
Recently, the development of small-scale devices and microsystems for drug 
screening applications has received attention.  These ‘lab-on-a-chip’ devices typically 
rely upon optical methods such as surface Plasmon resonance (SPR) and fluorescence or 
electrochemical reactions on the sensor surface to d tect microbial growth and treatment, 
which allows many measurements to be taken in situ.  In addition, the relatively low cost 
of these devices enabled by batch fabrication allows for microsystems that are specific to 
particular assay types and applications.   
Particularly, microfluidic platforms have been widely used for drug discovery 
research. Microfluidics provide laminar flow to the reactor and supply uniform nutrients 
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for biofilm growth. This is critical to have precisely controlled conditions for bacterial 
biofilm experiments since growth of biofilms is stochastic. In Meyer et al144, a 







Figure 1.9: (a) Schematic of the microfluidic biofilm growth device, (b) Photo of the 
device setup138.  
 
The device was utilized to quantify the total biomass changes in various biofilm growth 
conditions including flow rate and different drug combinations42. The system utilized 
microfluidic growth reactors on glass coverslip substrates such as those utilized in 
fluorescence-based methods, with optical measurement performed by measuring changes 
in light transmittance through biofilms using COTS photodiodes.  The measurement 
technique provides an in situ method of overall biomass quantification that does not 
require a permanent fixture on the external equipment used in confocal and fluorescence 
methods, thereby allowing for highly paralleled biofilm testing at reduced cost. The 
results showed successful continuous biofilm growth monitoring. In addition, 
microfluidic systems are used for antimicrobial efficacy evaluation. Compared to the 
traditional macro-scale experiments, it does not requir  large sample volumes that are 
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oftentimes difficult and/or expensive to synthesize particularly for new drug 
development40.  
 
Figure 1.10: Measured optical density changes at the microfluidic platform. The results 
showed successful biofilm growth monitoring.144  
 
 Fluorescence imaging methods have been integrated wi h microfluidic systems in 
a number of cases, allowing for increased control over the growth conditions of bacterial 
biofilms while taking advantage of a highly accurate and easily implemented optical 
detection method43.  Fluorescence microscopy systems of this type utilize fluorescent 
protein expression or cell staining methods to perform bacteria imaging and 
quantification of biofilm growth via cell colony counting or bacterial density.  Similarly, 
laser confocal microscopy systems enable in-depth analysis of localized biofilm 
structures with respect to cell viability, surface roughness and morphology, and cell 




Figure 1.11: A microfluidic flow cell enabling gradient efficacy testing of eight 
concentrations of antibiotic simultaneously in a single device.42   
 
 
The device produced by Kim et al44  enables testing of different bacterial signal 
concentrations on biofilms formed in microchambers by integrating a gradient mixer into 
a microfluidic flow cell.  The device produces result  similar to those that could be 
obtained through traditional macroscale methods using lower reagent volumes and more 
parallel experimentation, with analysis of biofilm growth being performed via confocal 
microscopy at select points in time.   
 For extensive analysis and detection at the molecular level, microscopic systems 
have also been integrated with ELISA methods in order to utilize specific fluorescent 
labels to detect the presence of target antibodies within a solution, such as bacterial 
biofilm cells.  While this and similar fluorescent microscopy-based methods are 
extremely accurate and provide precise information with regards to the development of 
bacterial biofilms, they require expensive and complex equipment for biofilm 
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measurement and, without a permanent fixture upon the microscope stage to perform 
continuous in situ measurement, are limited explicitly to end-point measurements [6].    
 In order to enable continuous measurement of bacteri l biofilm development 
without the use of optical measurements, electrochemical sensors have been developed 
that are able to detect biofilm growth with respect to both time and position within a 
microfluidic reactor.  Sensors of this type detect the presence of bacterial biofilms 






1.4.3   Biofilm Sensing 
Biofilms are composed of a group of bacteria surrounded by an extracellular 
matrix with diverse proteins. Thus, the amount of ttal biomass is correlated to the 
growth of biofilms45. Biomass detection has been achieved based on capacitance46, 
impedance47, fluorescence48, and acoustic wave49 sensing techniques. These methods can 
be applied for either a macro-scale50 or micro-scale device.  
Colorimetric assays are traditional methods for total biomass quantification based 
on optical density changes in a specific wavelength. In the assay, typically a dye can bind 
with specific chemical functional groups. Sequentially, the dye is detached by a releasing 
solution and measured the optical density by a spectrophotometer. For instance, crystal 
violet assay is one of most frequently used for biofilm studies especially 51. The dye can 
stain the cell wall and extracellular matrix of the biofilm resulting in quantitation of the 
total biomass. This colorimetric assay is typically utilized to investigate major changes of 
total biomass in biofilms at the end point of experiments52.  
Monitoring of electrical parameter changes as biofilms are established, such as 
capacitance and impedance, is demonstrated in microscale devices. A capacitance change 
based biomass detection sensor has been shown for biosensing applications53 , 54. In 
Ghafar-Zadeh et al.55, a dual channel microfluidic device, as shown in figure 1.12, based 
on a CMOS platform has been demonstrated for continuous bacterial growth monitoring. 
As bacteria grow in the channel, the dielectric consta t of the bacterial suspension is 
changed. The changes of the dielectric constant affect the capacitance at the gate of the 
CMOS device. This capacitance-based biofilm monitoring system shows high sensitivity 
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Figure 1.12: Schematic of differential bacteria growth monitoring using on-chip capacitive sensor43 
(255 mV/fF ≈ 10-12 g), but it requires a continuous power supply and  signal converter 









The impedance measurement along biofilm growth has been investigated56, 57. The 
electric impedance of bacterial suspension is composed of resistance, capacitance, and 
inductance which can change during biofilm growth. In E. Spiller et al.44, the group 















The 2 by 5 arrayed impedance measurement chamber is shown in figure 1.13. Each well 
has three electrodes, which are working, reference, and counter electrodes. The 
impedance is measured when a constant potential was applied between working and 
reference electrodes. Although this method showed a 105 CFU/mL ≈ (10-9 g) detection 
limit44, a constant power source requirement for the continuous measurement can be a 
challenge for real-time long term biofilm detection including both in-vitro and in-vivo 
applications.  
Biofilm labeling with fluorescence molecules is one of the well-established 
techniques for bacterial detection58. The procedure is not complex andthe sensitivity is 
very high. For instance, a fluorescent immunosensor for bacterial detection was 
demonstrated in Heyduk et al.59. Two samples of the antibody were prepared, each 
labeled with nanometer-sized flexible linkers with short complementary oligonucleotides 
modified with fluorochromes that could participate in fluorescence resonance energy 
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transfer (FRET) to increase the sensitivity. A fluorescent image showing the binding of 





Figure 1.14: Fluorescence microscope image (a) fluorescent signal from the 
oligonucleotides proximity due to the bacteria binding, (b) light transmittance image in 
the same area Fluorescent biofilm quantification47 
 
Based on the selective live/dead cell staining in biofilm, biofilm imaging work have 
demonstrated  via fluorescence as an extremely sensitiv  method to visualize as well as 
quantify total biomass in a small scale device. Confocal microscopy is a representative 
method for biofilm visualization and has revealed details of biofilm composition. 
However, this biofilm imaging method requires bulk and expensive external equipment. 
In addition, the quantification area is relatively small due to the limited observation area 
of the microscope compared to other colorimetric assay and impedance monitoring 
platform.  
The fluorescent biofilm quantification method is only an end-point measurement and also 
requires extra work for labeling which cannot be available in environmental and/or 
clinical biofilm monitoring systems such as water pipes and hospital infections. In 
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addition, due to the degradation of the fluorescence proteins, the labeling of the protein 
shows limited lifetime for measurements60.   
Surface Acoustic Wave (SAW) sensors have demonstrated  highly sensitive 
mass detection capability61,62. When an electric potential is applied at the interdigitated 
electrodes on a piezoelectric substrate, mechanical displacements are induced and 
propagated on the surface based on the reversible energy conversion between mechanical 
and electrical energy domains. The phase velocity of the waves is decreased when an 
additional mass is loaded50. The changes of velocity can be detected by monitori g the 
resonant frequency of the device49, 50.  
In M. Bisoffi et al.63, viruses are detected by a SAW sensor. The surface of the SAW 
sensor was functionalized using a specific antibody f r an interesting virus as shown in 
figure 1.8. As viruses bind to the antibody, the phase velocity of the SAW is decreased 
resulting in changes of the sensor operational frequency. The sensitivity of the sensor 






Figure 1.15: Schematic of the antibody-based virus surface acoustic wave biosensor. N-
avidin protein is used as an intermediate layer for the antibody immobilization on the 
surface. The antibody is attached on the N-avidin protein. Virus has a specific structure to 




In S. Krishnamoorthy et al.64, a highly sensitive SAW sensor was demonstrated for an 
interlukin-6 detection which is one of the key molecules in the human immune system. A 
specific antibody was immobilized on the surface of the SAW sensor as shown in figure 
1.16. The detection limit of the sensor was 10-18 g, which is the most sensitive method, 
using zinc oxide (ZnO) piezoelectric substrate.  
 
 
Figure 1.16: Schematic of the SAW sensor. A specific antibody for interlukin-6 was 
immobilized on the surface of the SAW sensor52.  
In table 1.1, the biomass sensing mechanisms are summarized. Since the SAW 
sensor is also a passive device, electric power to operate the sensor can be delivered by 
wireless coupling without a battery65. Based on that the SAW sensor requires an AC 
electric potential for operation and generates the AC electrical signal as the output, the 
sensor is compatible with a RF wireless communication system66 . The wireless 
compatibility, battery-less operation and high sensitivity of the SAW sensor make it a 
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1.4.4 Biofilm Treatment  
As previously discussed, biofilms are extremely difficult to treat once they are 
established. The concentration of antibiotics required to treat biofilms is 500 – 5000 times 
more than that in bacterial suspension6, 67. To increase the efficacy of antibiotic treatment, 
combination of different drugs or electric fields with antimicrobial agents has been 
investigated. 
In Cottarel and Wierzbowski et al.68, combinations of two or more antibiotics with 
adjuvants (cocktail therapy) were studied for bacterial infection treatment. The principles 
of bacterial treatment using antibiotics depend on the modes of the action of the agents, 
such as cell wall synthesis inhibition69, and DNA transcription blocking70. A scheme of 







Figure 1.17: Schematic of the antibiotic mode of actions. Each antibiotic has a unique 




For example, an aminoglycoside antibiotic blocks protein synthesis by ribosomes in 
bacterial cells. Hence, the antibiotic inhibits synthesis of essential enzymes resulting in 
cell death71. By combining two or more drugs, the treatment of bacterial infection can be 
enhanced based on multiple target attacks. However, combination of antibiotics can cause 
severe side effects due to unexpected interference between the antibiotics56 and induce 
generation of more antibiotic resistive bacteria72. The combined antibiotic therapy often 
cannot be a universal method for bacterial treatmen b cause of the severe side effects56. 
Furthermore, this method may be difficult to integrate with a microdevice due to the 
limited lifetime of drugs and delivery to specific locations especially considering in-vivo 
environments73.  
The efficacy of antibiotics for biofilm treatment can be radically enhanced if these 
agents are used under an electric field, known as the “bioelectric effect” 74, 75. According 
to several studies, the treatment effect of antibiotics combined with direct or alternating 
current (DC or AC) electric field resultsin improved treatment since the DC or AC 
electrical signal can provide additional biocidal effects to biofilm, such as local pH 
difference63 and biofilm permeability enhancement62. Costerton et al. reported the 
bioelectric effect for the first time76. In the paper, when antibiotics were combined with a 
DC electric field (5 V/cm),  enhanced biofilm treatment efficacy compared to other 












Figure 1.18: The treatment of biofilm in different treatment methods based on the cell 
viability studies (colony forming unit, CFU assay)64. 
 
In the results, when the antibiotic was combined with the electric field, the treatment 
efficacywas enhanced by approximately 6 orders of magnitude compared to the control 
(no treatment) and 3 orders of magnitude compared to antibiotic treatment only. However, 
the intensity of the electric field (5 V/cm) caused lectrolysis of the media since the 
intensity is higher than the limiting potential of the electrolysis inbiological fluids77. 
In Del Pozo et al. (2009)78, a comprehensive study of bioelectric effect using diverse 
antibiotics was reported. The testing set-up for the bioelectric effect investigation in 
different antibiotic treatments is shown in figure 1.19. It is composed of flow cells for 
growth media supply with electrodes to induce an electric field. Three biofilm strains are 
studied for the bioelectric effect: Psudomonas aeruginosa, Staphylococcus aureus, and 
Staphylococcus epidermidis biofilms. The electric current was applied for 20, 200, or 








Figure 1.19: Polycarbonate chamber detail (internal volume ≈ 16cm3 )66. 
 
The results of the study demonstrated improved biofilm treatments in all of tested 
bacterial strains. In addition, the study showed that e bioelectric effect is independent of 
the type of antibiotic as shown in the treatment results in figure 1.20.   
 





Figure 1.20: Averaged treatment efficacies with the standard deviations for Pseudomonas 
aeruginosa after exposure to four different treatments (i.e., antimicrobial agent alone, 




In Caubet et al. 79, an AC bioelectric effect implemented with a radio frequency electric 
field was demonstrated in a macro-scale set up (14 X 8 X 5 cm). The AC electric field is 
characterized to a 2 V/cm amplitude of sinusoidal signal at 10 MHz. The AC bioelectric 
effect also showed an enhanced biofilm treatment efficacy compared to only antibiotic 
treatment. Table 1.2 summarized the results of treatm nt in log-scale. 
 
 
Table 1.2: Treatment results of only antibiotics (Gentamicin, or Oxytetracycline), only 
AC electric field, and AC bioelectric effect67. 
 
The treatment efficacy of the AC bioelectric effect was enhanced approximately by one 
order of magnitude compared to antibiotic treatment only. Even though the efficiency of 
the AC bioelectric effect is not in the same order of magnitude as the DC bioelectric 
effect, it still showed an improved treatment of biofilm. 
Through the literature review, a DC or AC bioelectric effect has been 
demonstrated and characterized in a macro-scale exprimental setup which requires high 
sample volume and is challenging to integrate within a single system for clinical 
applications as summarized in table 1.3. More importantly, intensities of the electric field 
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used for the bioelectric effect were high resulting i  electrolysis of the surrounding media. 
The electrolysis of human serum can cause severe side effects due to the cell death80. 
 




(J.W. Costerton et al. 
Antimicrobial Agents and 
Chemotherapy, 1994) 
2 V/cm at 10 MHz 
(M. Giladi et al., Antimicrobial 
Agents and Chemotherapy, 
2008) 
Treatment Efficacy 6 log 1-2 log 
Set up 
(W X L X H) 
Macro-scale 
(8 X 31 X 3 cm) 
Macro-scale 
(8 X 14 X 5 cm) 
Challenges 
Electrolysis of media 
=> Biocidal molecules 
generation 
Electrolysis of media 
Relatively low enhancement 
Table 1.3:  Summary of parameters and challenges of DC and AC electric field 
bioelectric effect.  
 
 
However, the bioelectric effect is not only a general effect to diverse bacterial strains as 
previously shown in literature66, but also an independent method on the types of 
antibiotics66. Therefore, the bioelectric effect has an important dvantage for biofilm 
treatment that can potentially be a general treatment method with different types of 
antibiotics. The development of a new bioelectric effect utilized with a low intensity 
electric field without causing significant electrolysis of human serum is required to apply 
the concept of the bioelectric effect for clinical applications.  
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1.5   Summary 
Through the literature review focused on the biofilm detection and enhanced 
treatment aspects, both sensing and effective treatments are key required methods for 
biofilm associated problem management including clini al infectious diseases and 
environmental contamination challenges. As shown in the previous work, independent 
biofilm sensing and treatment methods are demonstrated with various approaches. 
However, integration of a sensor and an effective tr atment has not yet been 
demonstrated which has significant impacts in terms of developing new technologies as 
well as practical applications contributing to overcome biofilm associated challenges 
especially infectious diseases.  
In the rest of thesis, each component of the integrat d system that include a newly 
developed biofilm SAW sensor and bioelectric effect biofilm treatment using 
superposition field of AC and DC signals is described in details of design, fabrication, 
testing and discussion of the results. Finally, a successfully integrated system with the 




Chapter 2: Biofilm Sensor 
Based on the literature review, an integrated microsystem is an ideal solution for in-vivo 
and in-vitro biofilm monitoring and treatment. In this chapter, design, fabrication and 
testing reuslts of the biofilm sensing component of he system is presented based on the 
principles of the surface acoustic waves.  
 
2.1 Principles of the SAW Sensor 
Surface Acoustic Waves (SAWs) are generated on piezoel ctric materials when an 
electric potential is applied to interdigitated electrode transducers (IDT). The IDT induces 
a uniform electric field on the piezoelectric material which generates mechanical 
displacements based on the piezoelectricity of the substrate. The induced mechanical 
displacements cause electric potential differences due to the reversible piezoelectricity 
from mechanical to electrical energies. Based on these energy conversions on the 
piezoelectric substrate, the mechanical displacement (surface acoustic wave) can 
propagate on the surface of the piezoelectric material. A high piezoelectric coefficient 
(coupling coefficient) material is critical to achieve a highly sensitive SAW sensor by 
minimizing energy loss of the conversion81. A diagram of energy conversion and a 
schematic of propagation in the substrate are shown in figure 2.1 and 2.2 respectively.  
The wavelength of the SAW is related to the distance between the two electrodes in 
IDT; half of the SAW wavelength is equal to the distance of the two electrodes34. Since 
the input electrical signal is an alternating current (AC) signal, a standing mechanical 



















The standing wave is satisfied at the specific condition that the separation of the electrode 
pair is equal to an integer times half of the SAW wavelength83. Theoretical relations 





















nd =                     (1) 
λ⋅= fv                  (2) 
                                  (3) 
  
where d is the separation of the IDT electrode pair, λ is the wavelength of the SAW, n is 
an integer, v is the SAW speed, f is the operational frequency, C is the shear modulus of 
the substrate, and ρ is the density of the substrate. The velocity of the acoustic wave is 
inversely proportional to the square root of applied mass on the surface of the substrate as 
shown in equation 3. Thus, mass loading on the surface decreases the SAW velocity. The 
velocity of the SAW on the piezoelectric material is proportional to the resonant 
frequency because the wavelength is a constant set by the IDT. Therefore, the velocity 
change of the SAW due to mass loading can be monitored by measuring resonant 
frequency shifts. Since the speed of SAW is an intrinsic material property, the operational 
frequency of the sensor is designed based on the patt rn of the IDT (electrode separation 
distance) and the selected piezoelectric material.  
The sensitivity of the SAW sensor is extremely high since the speed of the wave is 
usually faster than other acoustic waves. For instance, a SAW propagates on a ZnO layer 
with approximately 4814.4m/s in S. Krishnamoorthy et al.84. Based on the relation 
between operational frequency and velocity of the wave, a 1 m/s change in speed, which 
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is equal to 100 pg of mass in S. Krishnamoorthy et al., induces approximately a 1 MHz 
frequency shift. Thus, SAW sensors have been used for extremely sensitive molecular 
sensing applications. In addition to the high sensitivity, the SAW sensor can be fabricated 
using biocompatible materials, such as gold, zinc oxide, and silicon allowing the sensor 
application to biomedical fields. Based on these advantages, the SAW sensor can be a 
sensitive transduction method for real-time biomass growth monitoring applications.  
 
2.2 Love mode SAW 
 The standing mechanical wave, which is induced by the electric field at the IDT 
on the piezoelectric material, propagates on the surface based on the reversible 
piezoelectricity of the substrate85. Depending on the lattice structure of the substrate, two 
possible propagation modes of the SAW, which are call d Rayleigh and Love modes, can 
be generated.  
Lord Rayleigh discovered the vertical SAW mode of propagation and, in his classic 
paper, predicted the properties of these waves86. Named for their discoverer, Rayleigh 
waves have a longitudinal component and a vertical shear component as shown in figure 
2.3. The Rayleigh SAW amplitude is typically about 10 Å and the wavelength ranges 









Figure 2.3: Schematic of Rayleigh mode SAW propagation88 
 
This amplitude and frequency can couple with a medium placed in contact with the 
device’s surface since Rayleigh waves have all their acoustic energy confined within one 
wavelength of the surface. Such coupling between th surface of the sensor and external 
media strongly affects not only the amplitude, but also the velocity of the wave. This 
feature enables SAW sensors to directly sense mass and mechanical properties of the 
contact media, such as shear modulus and thermal exp nsion coefficient. One of the 
disadvantages of the Rayleigh mode of SAW is that because the wave is a surface-normal 
wave, it makes the SAW device poorly suitable for liquid sensing application. When the 
Rayleigh mode SAW sensor is contacted by a liquid, compression waves are created, 
causing an excessive attenuation of the acoustic wave. As a result, Rayleigh mode SAW 
sensors are usually used for dry environmental sensing, uch as temperature and pressure 
sensors89. 
Propagation of the SAW 
Vertical and Shear Component 
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On the other hand, if the cut of the piezoelectric crystal material is rotated appropriately, 
the wave propagation mode changes from a vertical shear SAW sensor to a shear-
horizontal surface acoustic wave (SH-SAW) sensor90, as shown in figure 2.4. Augustus 
Edward Hough Love predicted the existence of the SH-SAW wave mathematically in 
1911. The lattice motion of a Love wave forms a horizontal line perpendicular to the 
direction of propagation (i.e. are transverse waves). Hence, it is critical to deposit a 
highly oriented c-axis piezoelectric material to generate a Love mode SAW91. When the 
SAW IDT is aligned perpendicular to the c-axis of the piezoelectric material, Love mode 
waves are predominantly generated. This Love mode SAW dramatically reduces the 
losses when liquids come in contact with the propagatin  medium, which allows Love 











Figure 2.4: Love mode SAW propagation64 
Propagation of the SAW 
Shear Horizontal Component 
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Love wave devices also offer the advantage of concentrating the acoustic energy in the 
guiding layer grown on an appropriate substrate, thus offering the opportunity of higher 
mass sensitivities. Several Love mode SAW sensors operating in both gaseous and liquid 
media have been demonstrated93, 94.  
 
 
2.3 Piezoelectric Material for the SAW Sensor 
A SAW is generated on the piezoelectric material which operates at a high frequency 
oscillation governed by the design of the IDT. To obtain the maximum acoustic wave 
energy from the input electrical energy, the deposition of a high piezoelectric coefficient 
material as a substrate is the most important parameter of the SAW sensor as well as its 
high quality deposition method95, 96. The piezoelectric coefficient is defined as the ratio 
between mechanical energy and electrical energy97 (equation (4)).  
energyelectrical
energyacoustic
tcoefficienricpiezoelectK =)(2      (4) 
 
ZnO is a piezoelectric material with the highest piezoelectric efficiency along with 
Lithium Niobate (LiNbO3)98. Another advantage of ZnO is a biocompatibility of the 
material99 that enable to apply for diverse biomedical devices100. Moreover, ZnO can be 
grown by thin film deposition methods, such as radio-frequency (RF) sputtering and 
pulsed laser deposition (PLD) with low limit of the substrate101, 102. A high quality ZnO 
thin film deposition process is well developed and compatible with traditional 
photolithography techniques. The PLD is one of the common ZnO deposition methods 
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for high quality film growth103, 104. PLD has several advantages and benefits over othe
growth techniques, including high control over growth parameters, precisely controlled 
growth rates, and low temperatures. Due to its relativ ly simple set-up and operation, it 
has been widely used in research. ZnO with a high pezoelectric coefficient is capable of 
generating very high frequency (GHz) SAW and when combined with a SiO2/Si substrate 
it can be an excellent material choice for Love mode propagation105. Based on its 
piezoelectric properties, biocompatibility, and the igh quality fabrication process, ZnO 
is the piezoelectric material for the biofilm sensor design.  
 
 
2.4 Passivation of the Piezoelectric Layer 
The ZnO film is soluble when in contact with a non-neutral pH liquid or after long 
term moisture exposure106. Zinc (Zn) has less ionization energy, which is the minimum 
required energy to become an ion respected to the energy of hydrogen (H). As a result, 
when non-ionized Zn and H atoms are in the same solution, Zn will be ionized in the 
solution due to the smaller ionization energy than H, resulting with generation of 
hydrogen gas. Because of this solubility of ZnO, a SAW sensor based on ZnO layer is 
challenging for biosensor applications107, 108. Specifically in this work, when the ZnO 
film was placed in the bacterial growth media without a passivation film, the ZnO layer 
was dissolved completely within three hours. Therefore, the ZnO film-based SAW sensor 
for biosensor applications is required to fabricate  passivation layer that can minimize 















mechanical properties of the passivation film, such as shear modulus and density, are 
critical parameters to prevent significant sensitivity loss due to the mismatch in material 
properties. To study the sensitivity dependence in different passivation materials, a 
theoretical model for the biofilm SAW sensor was developed that is focused on the 
elastic modulus of the material, as shown the schematic of the cross sectional view of the 











Figure 2.5: Schematic of passivation SAW sensor for bi film detection109 
 
where x is the biofilm thickness, h is the thickness of the passivation film, and d is the 
thickness of ZnO film. The bacterial growth over the sensor was assumed to be uniform, 
so that mass loading depends only on the thickness of the biofilm (x). In addition, the 
SAW velocities were assumed to be equal both in the bottom and top ZnO layers, 
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yielding V1 = V2 as indicated in figure 2.5 to simplify the model calculation (no 

























v is the mass sensitivity of the SAW sensor, v0 is the initial SAW velocity before 
mass loading, ∆m is the amount of the mass loading, and ∆v is the SAW velocity change 
due to the mass loading. Based on the uniform bacteri  growth assumption and from 
equation (5), a one dimensional mass sensitivity for the SAW sensor can be derived as 









                              (6)
 






                                              (7) 
 
where v is the SAW velocity, C is the shear modulus, and ρ is the density of the surface. 
The acoustic wave velocity in the passivated SAW sensor can be defined as a function of 
passivation film thickness (h), density (ρ), and biofilm thickness (x) for non-passivated 














































































    (9) 
 
where Cfilm is the shear modulus of the passivation film, h is the thickness of the film, and 
d is the thickness of the ZnO, as shown in figure 2.5. In the passivated SAW sensor 
calculation, the total shear modulus, including ZnO and passivation film, was calculated 
by the series mechanical spring model, since the mechanical displacement in the IDT is 
transferred from the ZnO film to the passivation film sequentially97. In equations (8) and 
(9), the key variable for the velocity is bacterial biofilm thickness (x), and the other 
parameters can be determined to investigate the sensitivity of the sensor. Some potential 
passivation materials, such as silicon nitride, aluminum oxide, and silicon dioxide, were 
selected based on the mechanical properties similarties to ZnO film and also water 
resistivity. The mechanical properties of the potential materials are summarized in table 
2.1. Using these parameters and equation (9), the velocity function was defined 
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depending on the biofilm thickness. The normalized v locity in each material was plotted 





















Figure 2.6: Relative SAW velocity from some candidate materials 
 Shear modulus (Cfilm) Poisson ratio Density (ρfilm) 
ZnO 44.28 GPa 0.30 5.606 g/cm3 
Si3N4 80.60 GPa 0.24 3.290 g/cm
3 
SiO2 32.19 GPa 0.17 2.606 g/cm
3 
Al 2O3 124.0 GPa 0.21 3.950 g/cm
3 
Teflon 0.005 GPa 0.46 2.199 g/cm3 
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Compared with a non-passivated SAW sensor, the velocity in the passivated SAW sensor 
was always more attenuated due to the passivation film mass loading and mismatch in 
mechanical properties as shown in figure 2.6.  
The relative sensitivity of the passivated SAW sensor can be calculated by the fact that 
the sensitivity is proportional to the SAW velocity change during the biofilm growth 
which corresponds to the slope of the curve as shown in figure 2.6. The differentiated 
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In figure 2.7, the normalized sensitivity for the potential passivation materials was the y 
axis intercept, since that is the point described in equation (6) where biofilm (x) 
approaches zero. The theoretical normalized sensitivity of SAW sensors passivated with 
















Figure 2.8: Normalized sensitivity from different passivation SAW sensors 
 


















Based on the numerical analysis, aluminum oxide passiv ted SAW sensor showed better 
sensitivity than other materials, and Teflon was the worst choice for this application, even 
though Teflon is one of the most common biocompatible materials for biomedical 
applications. Therefore, Al2O3 was chosen as a potential passivation film for the SAW 









Figure 2.9: Schematic of the passivated SAW sensor 
 
 
2.5 Design of the SAW Sensor 
Based on the sensitivity studies of the passivated SAW sensor, the sensor was 
designed with considerations for future in-vivo biofilm monitoring applications. The 
resonant frequency of the SAW sensor was chosen based on the regulation for 
implantable medical devices set by the Federal Communication Commission. The SAW 
sensor was fabricated using biocompatible materials, such as gold, zinc oxide (ZnO), and 
silicon113. The SAW sensor is also a passive device. Thus, the required power for the 
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operation of the sensor can be delivered by RF inductive coupling114, 115, 116 enabling a 
batteryless system which is significant to future applications.  
The operational frequency of the SAW sensor is from 401 MHz to 406 MHz for 
Medical Device Radiocommunications Service (MedRadio). Based on the SAW velocity 
in our ZnO film (4812 m/s) and the fact that half of the SAW wavelength is equal to the 
separation of each electrode pair, the separation length of the IDT is designed to be 6 µm 
in order to achieve a 402 MHz operational frequency for the SAW sensor.  
Material for the IDT is also crucial since the IDT can induce the energy insertion loss 
from the input electrical energy to the piezoelectric substrate. The energy insertion loss 
depends on the acoustic impedance and spacing distance of the IDT electrode width. 
Some potential materials for the IDT are compared based on the acoustic impedance 
matching theory and reflective coefficient equation117, as shown in (10) and (11). 
 
 (10) 























where Z is the acoustic impedance, ρ is the density of the layer, v is the acoustic velocity 
of the material, R is the acoustic wave reflective co fficient, P0 is the incident power, P1 
is the reflective power, P2 is the transmission power, Z1, and Z2 are the acoustic 
impedance in each layer respectively. Aluminum and gold are selected as the IDT 
material and their properties were calculated based on equation (10) and (11). The results 
are shown in table 2.2. Lower value of reflective coefficient represents more energy 




ble 2.2: Acoustic wave reflection coefficient calculation results 
 
Based on the calculation results, gold (Au) was chosen as the material for the IDT. In 
addition to the acoustic impedance matching, the width of the electrode in the IDT also 
affects the energy insertion loss of the sensor118. Generally, the electric field in the 
piezoelectric material induced by the IDT is proportional to the gap distance between the 
electrodes indicating in figure 2.11. 
 
 










Figure 2.11: Cross sectional view of the IDT on the piezoelectric layer 
 
where d is 6 µm in the design, w is the width of the electrode, and g is the gap between 
two electrodes. If the width of the electrode, w in figure 2.11, becomes narrower, more of 
the electric field affects the piezoelectric substrate, so the efficiency of the mechanical 
displacement is increased105.  
The PLD for ZnO deposition introduces a specific frequency pulsed laser to the Zn 
target, and the material is deposited on the chip in the oxygen chamber. Since limit area 
of the target is exposed by the pulsed laser, the PLD only allows a uniform film growth in 
a small chip level process, not for the wafer process119. Because of this limited uniformity 
of the PLD, prior to the ZnO deposition, a wafer process need to be completed. 
Considering minimum feature of electrodes (2 – 6 µm) for the IDT, the electrode 
fabrication designed before ZnO deposition to achieve the feature size of the IDT through 
the contact lithography that is compatible with a wfer process rather than diced chips.  
After electrode fabrication, the wafer was diced anfollowed by the PLD ZnO deposition. 
Hence, the final scheme of the SAW sensor is an inverted structure that the IDT is 





















traditional SAW structure in figure 2.12(a), where the IDT is patterned over the 
piezoelectric material.  
 
       (a)                                                                       (b) 
 
   
 
Figure 2.12: Cross sectional views of (a) traditional SAW sensor and (b) inverted SAW 
sensor for PLD ZnO deposition 
 
 
Even though the traditional SAW sensor can achieve higher sensitivity than the other 
design based an additional mass loading affects directly on the SAW propagation120, 
there can be corrosion problems on the IDT, since the IDT exposed to the external 
environment directly. In the inverted SAW sensor design, the SAW, which is generated 
in the IDT, can disperse from the bottom to the top of the piezoelectric thin film area. As 
a result, the sensitivity of the sensor would be decreased based on the inverse relation 
between the sensitivity and SAW velocity dispersion ratio121. However, considering the 
total biomass of the biofilm is typically in hundres nano-gram or a few micro-gram, this 
structure still can detect the mass based on the previously demonstrated detection limit 
(10-18g). The sensitivity was characterized after the sensor was fabricated and shown 
appropriate detection limit (10-12g) for biofilm applications. Another advantage of this 
revised structure includes the reduced possibility of IDT corrosion than the traditional 
SAW structure since the IDT is covered by ZnO film. Furthermore, this new structure is 
 
compatible with the PLD for ZnO film deposition, whic  allows a high quality and 









Figure 2.13: Schematic of cross sectional view of the inverted SAW sensor
 
The thickness and fabrication process of aluminum oxide were characterized by empirical 
studies. The major objective
the minimum required thickness of the film 
prevent significant sensitivity loss 
deposited in the thicknesses 
deposition (ALD) on the ZnO layer. 
film deposition capability. 
The test chips were placed for two days in bacterial growth media, which is 
composed of diverse n
microscopy images of the 





s of the experimental work were focused on characterizing 
with an appropriate fabrication process 
due to the thicker film deposition. The Al
of 20 nm, 30 nm, 40 nm and 45 nm by atomic layer 
The ALD was chosen based on highly dense thin 
 
utrient and electrolytes for bacterial growth. The optical 
surface are shown in figure 2.14 All ZnO layers were damaged 




2O3 film was 
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passivation film will cause more loss of sensitivity due to the higher initial mass loading 
and dispersion of the waves122, an Al2O3 thickness of 45 nm is chosen for the passivation 
film.  
The deposition of aluminum oxide film on a ZnO layer can be achieved by other 
fabrication techniques. Since the density and uniformity of a thin film highly depend on 
the deposition technique, the 45 nm Al2O3 film was also fabricated by electron beam 
evaporation, sputtering and ALD. The test devices wre placed in the bacterial growth 
media for two days. The optical microscopy images are shown in figure 2.15. 
Interestingly, only Al2O3 deposited by ALD can protect the ZnO film from media ue to 








































Figure 2.14: Optical microscopy images of the surface of four different (20nm, 30nm, 
40nm and 45nm) thicknesses of Al2O3 film deposition on ZnO layer after two days in a 
bacterial growth media. The 45nm thickness of Al2O3 film successfully protected the 

























Figure 2.15: The optical surface images of the SAW sensor passivated by 45 nm Al2O3 
film using (a) e-beam evaporation (black dot is ZnO), (b) RF sputtering (dark area is 




In addition to the passivation film characterization n a bacterial growth media, the 45 nm 
Al 2O3 film passivated SAW sensors were tested in an animl serum (10% Fetal Bovine 
Serum). The FBS is composed of a number blood proteins and electrolytes simulating in-
vivo conditions123. The device surfaces were inspected after two daysincubation in the 






















Figure 2.16: The optical surface images of the SAW sensor passivated by 45 nm Al2O3 
film using (a) e-beam evaporation (arrows indicate ZnO residue), (b) RF sputtering (dark 
areas are is ZnO), and (c) ALD (no ZnO damage) in 10% FBS for two days28. 
 
 
As shown in the results, the ALD Al2O3 film only successfully protected the ZnO layer 
from the serum. Based on the thickness and fabrication process characterization studies, 
the 45 nm Al2O3 film deposited by ALD is used for the passivation film of the ZnO-based 
SAW sensor. Fabrication process specifications and design of the IDT of the SAW sensor 










Material Process Characteristic 
ZnO 
Pulsed laser deposition, 500 – 
600 nm 
Piezoelectric film 
Al 2O3 Atomic layer deposition, 45 nm Passivation layer for ZnO 
Au Evaporation, 200 nm Electrodes for IDT 
SiO2 PECVD, 60 nm 
Prevent SAW propagation to 
Silicon 
Si Substrate, 500 µm Substrate 
 
Table 2.3: Summary of the SAW sensor material specification 
 
Design of the SAW Description 
Wavelength of the SAW 12 µm (λ) for 402 MHz resonant frequency 
IDT electrodes 2 µm width and 4 µm distance 
(one pair takes 6 µm = λ/2) 
Distance between two IDTs 100λ = 1200 µm 
Thickness of ZnO λ/2 = 600 nm 
 




2.6 Fabrication Process 
 
 
2.6.1 Overall Process Flow 
 
 The fabrication process of the SAW sensor has been d veloped in the previous 
work27. A 60 nm silicon dioxide (SiO2) layer to prevent acoustic wave loss to silicon 
substrate was deposited on (100) Si substrates by low pressure chemical vapor deposition 
(LPCVD)27. The IDT was patterned using traditional photolithgraphy before depositing 
the ZnO film. Cr/Au (15 nm / 200 nm) as the IDT material was deposited on the wafer by 
electron-beam evaporation, followed by lift-off (figure 2.17). The wafer was diced before 
ZnO deposition by pulsed laser deposition (PLD). Crystalline (001) orientation ZnO (c-
axis oriented ZnO) films on SiO2/(100)Si substrates were grown by PLD. The laser 
deposition system used a KrF excimer laser at a wavelength of 248 nm with pulse 
duration of 25 ns to ablate a high purity (99.99 %) ZnO ceramic target. The ZnO layer 
was grown at 300 °C with an ambient oxygen partial pressure of ~1.0×10-4 Torr. After 
ZnO film deposition, the ZnO was patterned using a solution that consisted of phosphoric 
acid, acetic acid, and deionized water (1:1:30) with photoresist mask. The device was 
annealed at 800 °C for one hour to increase the resistivity of the ZnO124. Finally, the ZnO 
surface of the SAW sensor was coated by depositing an Al2O3 film using atomic layer 
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Figure 2.17: Microscopy image of the fabricated IDT electrode. The width of electrode is 











2.6.2 Pulsed Laser Deposition 
A single crystalline ZnO growth on the substrate is crucial to induce a shear 
horizontal mode of the acoustic wave (SH-SAW or Love wave) that is sufficient to use in 
a liquid environment without significant wave propagation loss. The induction of the 
wave is determined by the crystal orientation of the piezoelectric ZnO layer. A c-axis 
oriented (001) ZnO film is induced the Love wave. Since the wave propagates with a 
horizontal actuation of the amplitude, damping of the waves due to the water contact on 
the surface is significantly reduced. As a result, Love mode SAW was utilized to diverse 
biosensing applications in liquid environments126.   
The c-axis orientation of the ZnO can be grown by a RF sputtering, atomic layer 
deposition (ALD) and pulsed laser deposition (PLD). The sputtering provides advantages 
of wide uniform film deposition with high throughput, but the quality of ZnO is 
considered less than the other methods since concentratio  of impurities typically is 
higher than ALD and PLD127. The ALD is required expensive precursors as well as ow 
throughput of the process. The PLD provides the highest quality of the ZnO with 
extremely low concentration of impurities. The process is relatively simple138. 
Furthermore, the orientation of the ZnO is well contr lled due to the high stochastic 
correlation with the target material crystal structure128. Based on the high quality and 
single crystal ZnO film fabrication advantages, the PLD was chosen to deposit the 
piezoelectric ZnO film (600 nm) for this SAW sensor development. The schematic of the 








Figure 2.18: Schematic of the PLD. 
An external optical source generates a pulsed lasersignal (10 Hz, 248 nm of KrF excimer 
laser, 24 kV) that is aligned with the Zn target. The energy of the pulsed laser induces 
plasma condition on the target resulting in producing vapor phase Zn in the chamber. 
Oxygen reacts with the Zn vapor in the chamber and the film is grown on the substrate as 
the plasma is expanded toward the growth chuck. The critical parameters including the 
energy of laser, vacuum pressure, target quality, substrate temperature and alignment of 
the plasma plume to the substrate are crucial to have a consistent film growth rate. The 
thickness of the ZnO layer was aimed to be approximately 600 nm to maximize the 
sensitivity of the sensor based on the relation betwe n the ZnO thickness and the 
wavelength of the SAW; 5% of the wavelength is the optimal thickness of the 
piezoelectric ZnO layer52. The grown ZnO layer was investigated purity via spectrum 
analysis (photoluminescence spectroscopy) and orientat o  via X-ray diffraction (XRD).  
Photoluminescence spectroscopy (PL) is a process in which a substance absorbs 
photons (electromagnetic radiation) and then re-radiates photons. Quantum mechanically, 
this can be described as an excitation to a higher en gy state and then a return to a lower 
energy state accompanied by the emission of a photon. Depending on the bandgap energy 
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of material, the emission wavelength is different. Based on the distribution of the 
observed wavelength peaks, the material composition can be investigated. After ZnO film 











Figure 2.19: Photoluminescence spectrum of the ZnO layer, (380 nm wavelength is 
corresponding with the bandgap of the ZnO)  
 
 
As shown in figure 3.4, the peak wavelength of the emission light was in 380 nm. The 
ZnO has 3.3 eV direct bandgap, and it corresponds to the 380 nm wavelength of the light 
based on the energy and wavelength relation. Therefore, this result represents the high 
quality of ZnO deposition since there was no other peaks in the PL spectrum129.  
In addition, the crystal orientation of ZnO was investigated by the XRD to determine 
what is the preferred lattice texturing of the deposited ZnO thin film. XRD is a method of 
determining the arrangement of atoms within a crystal, in which a beam of X-rays strikes 
a crystal and diffracts into many specific directions130. From the angles and intensities of 
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these diffracted beams, a crystallographer can produce a three-dimensional picture of the 
density of electrons within the crystal. From this electron density, the mean positions of 
the atoms in the crystal can be determined, as well as their chemical bonds, their disorder 
and other crystallographic, including preferred lattice orientation information. The XRD 















Figure 2.20: XRD pattern of the ZnO film deposited by PLD 
 
To make sure that the Love mode SAW is generated, th  ZnO film should be deposited in 
the c-axis direction (00L) so that the c-axis of its crystal lattice is perpendicular to the 























substrate. As shown in figure 3.5, the diffraction angle of the X-rays at 34.25° and 72.25° 
(2θ) corresponding to the (002) and (004) lattice direct ons, were the most intensive 
reflections in the PLD-prepared ZnO film.  
Based on these ZnO layer characterization results, it is concluded that low impurity c-axis 
oriented ZnO layer was successfully deposited by the PLD. 
 
 
2.6.3 Atomic Layer Deposition 
Atomic layer deposition (ALD) process contributed to the scaling down of electronic 
devices into the nano-meter regime due to its highly dense and conformal film coating 
capability. ALD can control the thickness of film from a single to thousand atomic layers 
of the material which is critical to fabricate precise and robust microelectronic systems at 
a low temperature (~ 150 ºC)141. This process has been widely used for diverse industry 
and research areas including CMOS, microfabricated devices and biochips131. The ALD 
was utilized in this thesis work for fabrication of a passivation layer for long term reliable 
operation of the SAW sensor. An ALD Al2O3 film was used for the sensor as a protecting 
layer of the ZnO from degradation due to long term xposure to biological fluids.  
Aluminum oxide (Al2O3) is well known for its biocompatibility and stability
132. 
Several methods of fabricating Al2O3 films are available, including RF sputtering, 
evaporation and ALD. RF sputtering and e-beam evaporation of Al2O3 targets as well as 
ALD Al 2O3 were compared in terms of their ability to efficiently passivate the device in 
the liquid environment. The passivation performance of the Al2O3 films were investigated 
in bacterial growth media (Lysogeny Broth) and animal serum (10% Fetal Bovine Serum). 
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The Al2O3 film passivated devices were placed in the growth media for two days and the 








Figure 2.21: Schematic of the atomic layer depositin process of aluminum oxide. 
Trimethylaluminum (TMA) and water are used as liquid precursors at 150 ° C. 
 
Figure 2.21 shows images of the passivated ZnO layer for each of the three deposition 
techniques. The thickness of the deposited Al2O3 film was 45 nm as optimized by parallel 
studies performed with films of varying thickness previously. It was observed that while 
sputtered and evaporated passivation layers gradually dissolved in both media, the films 
deposited using ALD can effectively passivate the device even after prolonged exposure. 
This is attributed to the conformity and thickness control of ALD, which result in the 
formation of highly dense nanometer thick films compared to physical vapor deposition 
techniques. These results demonstrate the suitability of ALD for the reliable passivation 
of biomedical ALD was an enabling technology for reliable biosensor developments.   
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Figure 2.22: Optical microscopy images of the surface of the device in different 45 nm 
thickness Al2O3 film fabrication processes: (a) and (b) from RF-sputtering Al2O3 film 
(ZnO damage in both media), (c) and (d) E-beam evaporation Al2O3 film (ZnO damage 
in both media), (e) and (f) from ALD Al2O3 film (no ZnO damage), (arrows indicate ZnO 
damages)28 
 
The Al2O3 ALD thin films were fabricated at 150 ºC in a flow-through chamber 
system of the Beneq TFS-500. First, water vapor (H2O) that was used as the oxygen 
source was absorbed on the substrate and formed a hy roxyl group. This was followed by 
the introduction of Trimethyl aluminum (TMA) liquid precursor into the ALD reactor. A 
covalent bond between the TMA and hydroxyl group is formed creating a single atomic 
layer deposition that decomposes into Al2O3. Each deposition cycle (500 ms) consisted of 




2.7 Testing Setup and Experiments 
The ALD aluminum oxide passivated SAW sensor was tested for biofilm growth 
monitoring. The resonant frequency of the SAW sensor was measured by a network 
analyzer (HP8510, Agilent Inc., USA). The network analyzer consists of the sweeper, the 











Figure 2.23: Schematic of the network analyzer 133 
 
The sweeper or synthesizer provides the RF stimulus to the test set from 10 MHz to 26.5 
GHz. The test set supplies the RF signal for the device resonant frequency analysis. 
Together these comprise a complete stimulus / response test system which provides 
stimulus to the device under test and measures the ignal transmitted through the device 
(S21) or reflected from its input (S11). The system then detects and processes the data to 























enhancement techniques permit measurement calibration  the interface to the device 
under test, minimizing the effect of systematic measurement errors. Many electrical 
properties of networks of components, such as inductors, capacitors, and resistors, may 
be expressed using S-parameters. For instance, the syst m gain, return loss, voltage 
standing wave ratio (VSWR), reflection coefficient, and amplifier stability can be 
measured by analyzing S-parameter values. The scattering refers to the way in which the 
traveling current and voltages in a transmission line are affected when they meet a 
discontinuity caused by the insertion of a network into the transmission line. This is 
equivalent to the wave meeting an impedance difference from the line’s characteristic 











    
 
Figure 2.24: Four S-parameters in the network analyzer, where a1 is the forward reference 
which is provided by the synthesizer in wide frequency range RF stimulation, b1 is the 
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reflected signal from the testing device, b2 is the transmitted signal through the device, 




Based on these S-parameter definitions, a resonant frequency of testing system can be 
measured. The minimum value of S11 at a frequency means that the least RF energy 
reflection occurs at the frequency. Most RF energy t ansmits through the device because 
the impedance between the test device and energy source are matched demonstrating the 
resonant frequency of the tested system. In addition, he resonant frequency of the device 
can be monitored by the S21 maximum values. The S21 high peak at a frequency 
represents the transmission of the most RF energy at that frequency since the impedance 
is matched. Therefore, a resonant frequency of the test device can be measured by 
monitoring either the S11 low peak or the S21 high peak at the network analyzer.  
The measured resonant frequency data was saved in the computer which 
communicates with the network analyzer by the GPIB. The GPIB communication and 
data saving program were designed using C++ language. Biofilm growth experiments 
typically span more than 48 hours, so the data sampling rate does not have to be fast, 
such as in 10 seconds rate per biofilm testing device. In addition, the only data needed to 
monitor the device’s resonant frequency shift during bacterial growth are either the S11 
low peak or S21 high peak reducing the amount of data saved as opposed to saving the 
entire waveform. Based on these considerations, the program was designed to save either 
the low peak of the S11 or high peak of S21 that it was possible to expand the experiment 
time without concern for the data capacity. In addition, the data sampling rate can be set 
by a user when the experiments are initiated. Typical data sampling rate for four parallel 
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experiments was 4 minutes for each device. The full C++ code is shown in the Appendix 
A. 
  The testing setup requires consideration of natural properties of biofilms 
including their growth variation, temperature and fresh media supply. A custom made 
device package for a stable electrical connection was developed and is shown in figure 
2.25. The resonant frequency of the sensor during bofilm growth was monitored by a 
network analyzer (HP 8510B).  E. coli K-12 W3110 was used as a bacterial model for the 





































Figure 2.25: A custom made the SAW sensor package for bacterial biofilm growth 
experiments (The input and output of the sensor are connected with the network 
analyzer)27. 
 
In preparation of bacterial suspension, a 20 µl frozen culture of Escherichia coli K12 
W3110 (wild type) was innoculated in a 5 mL of Luria Broth (LB) bacterial growth 
media in a cell culture tube. Then, the bacteria were cultured overnight in the 250 rpm
shake incubator at 37 °C. The optical density (OD600) was measured after the overnight 
culture growth by a spectrophotometer, and the OD600 was typically in 4.20 - 4.50 ranges.  
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An 1 mL of the overnight cultured bacteria was diluted 20 times by adding LB media to 
achieve the initial bacterial concentration to be OD600 ≈ 0.21 - 0.23. The total volume of 
the bacterial growth well is approximately 20 mL. During the biofilm growth 
experiments, the well is placed on the hotplate set at 37 ºC and sealed the surface by a 
paraffin film to prevent significant evaporation of the media.  
 
2.8 Biofilm Detection of the SAW Sensor 
An E. coli suspension (OD600 ≈ 0.25) was placed in the bacterial growth well of the
package with 10% FBS. The resonant frequency of the sensor was monitored for 48 
hours. The negative frequency shift (decrease of the resonant frequency) of the sensor is 
correlated to the amount of biomass loaded on the sensor. A newly fabricated SAW 
sensor was used for three consecutively biofilm growth experiments. Between the 
experiments, the chip was cleaned by oxygen plasma for 30s at 150 W RF power. To 
confirm the sensitivity of the sensor, 10 µl of deionized (DI) water was loaded and the 
resonant frequency changes were measured by the network analyzer before each biofilm 
growth experiment. The negative frequency shift results of the SAW sensor in the 
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Figure 2.26: Resonant frequency shifts of the SAW sensor in three consecutive biofilm 
growth experiments. The growth media was 10% Fetal Bovine Serum to simulate an in-
vivo condition for a future implantable environment. The results show repeatable 
responses of the sensor27. 
 
In figure 2.26, the SAW sensor showed repeatable biofilm monitoring results over three 
consecutive biofilm growth experiments. At the beginning of all three experiments, the 
response indicates exponential bacterial growth, corresponding to natural bacterial 
growth. After 24 hours, the stationary stage of bioilm growth was observed. Furthermore, 
the variation of the frequency changes in the station ry stage was only approximately 0.3 
MHz, which indicates reliable operation of the SAW sensor in the animal serum. Growth 
of biofilms on the sensor was also confirmed by inspecting the surface of the sensor using 















Figure 2.27: Optical microscopy images of the surface of the SAW sensor (a) before 
biofilm growth and (b) after biofilm growth27.  
 
 
The detection limits of the sensor using 10 µl of deionized (DI) water are summarized in 
table 2.5. The results show an excellent sensitivity recovery of the sensor. Based on the 
highly dense and conformal passivation of the ZnO layer using ALD, the performance of 























As shown in the results, the SAW sensor successfully demonstrated real-time 
biofilm growth detection. The sensor was fabricated using a c-axis oriented high quality 
ZnO deposited by PLD. To achieve reliable operation of the sensor in a biological 
solution, the ZnO layer was coated by 45 nm Al2O3 film fabricated by an atomic layer 
deposition. Based on the novel ALD Al2O3 film passivation, the SAW sensor can be used 
in multiple biofilm growth experiments without losing sensitivity. The detection limit of 
the SAW sensor studied by 10 µl DI water loading was approximately 5.3 pg. These 
results support further development of an integrated microsystem for biofilm monitoring 
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Chapter 3: Biofilm Treatment 
When bacteria are still in the pre-biofilm stage, antibiotic treatment can inhibit 
bacterial growth based on the minimum inhibitory con entration (MIC) of each antibiotic 
for the type of bacteria used134. However, once biofilms are formed, treatment requires 
500 – 5000 times higher doses compared to the concentration needed to treat bacterial 
suspension. Therefore, developing an effective biofilm treatment is critical to avoid 
severe antibiotic side effects due to such high antibiotic concentration requirement. When 
an antibiotic and an electric field are introduced to biofilms simultaneously, the treatment 
efficacy of the antibiotic can be significantly improved in a phenomenon known as the 
bioelectric effect. In this chapter, a newly develop d bioelectric effect using a 
superimposed electric signal is presented. The superim osed electric field method 
resulted in an improved biofilm inhibition. 
 
3.1 Development of Bioelectric Effect Using a Macro-scale Setup 
3.1.1 Superpositioned Electric Field 
As discussed in the previous literature review, the bioelectric effect improves the 
biofilm treatment efficacy without depending on thestrain of bacteria as well as types of 
antibiotics29, 62, 63, 64, 66, 114. The biocidal effects of electric fields have been investigated 
for several decades. The effects of biocidal and antimicrobial agents are enhanced when 
used under the influence of electric fields135. Costerton and colleagues demonstrated 
improved biofilm treatment through the application f either a direct or alternating 
current (DC or AC) electric field111, 113. Many hypotheses have been suggested to explain 
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the fundamental mechanisms underpinning the BE, including both an improvement of 
antibiotic binding efficiency to biofilms by an external electrostatic force136 and increased 
membrane permeability due to local molecular vibratons induced by an AC field137. 
Oxidants generated by the imposed electrochemical conditions also affect the activities of 
antibiotics including byproducts of electrolysis of the medium138. However, previously 
demonstrated bioelectric effects were utilized using higher than 0.82 V resulting in 
electrolysis of the surrounding biological media65. Therefore, a new bioelectric effect 
with low intensity of electric field needs to be investigated particularly considering for in-
vivo biofilm infection treatment.  
Although studies have presented improved biofilm treatment through AC and DC 
field treatment independently, a combination of both AC and DC fields for the BE has 
not appeared. A superpositioned (SP) electrical signal that simultaneously imposes both 
an AC and DC electric force is applied for the matured biofilms. Based on the suggested 
biocidal mechanisms of AC and DC fields with antibiotics, the SP field is expected to 
induce an enhancement of the biofilm treatment efficacy. The AC field can induce 
permeability of extracellular matrix (ECM) in biofilms which have a lot of partial charges 
due to the molecular local vibration of the ECM74, 79. The molecular vibration results in 
increased porosity of the matrix that antibiotic can diffuse through the layer effectively. 
The DC field provides consistent a directional electrostatic force to the biofilm. This 
induces local electrolyte non-uniform distribution resulting in pH changes, oxygen 
depletion, and nutrient or drug gradient112. This imposed condition increases metabolic 
biocidal stress to bacteria in biofilms. Thus, when the AC and DC field are applied for 
biofilm concurrently, the biocidal effect of the antibiotics can be dramatically intensified.  
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The intensity of the SP electric field was characterized based on minimizing 
electrolysis of biological fluid. Since the electrolysis produces hazardous radicals, the 
lower voltage application for the SP field was significantly considered for the 
characterization. The required voltage was determined to be 0.5 V that is well below the 
threshold electrolysis voltage (0.82 V) for 4 mm distance of two electrodes creating an 
1.25 V/cm of electric field. The intensity was applied for the amplitude of both AC and 
DC signals. Frequency of the AC component was chosen by 10 MHz based on the 
previous literature139. Thus, the SP field was characterized as 1.25 V/cm sinusoidal signal 

















The antibiotic selected for this work was gentamicin (Invitrogen Inc. USA). 
Gentamicin is one of the aminoglycoside antibiotics, which disrupt protein synthesis by 
ribosome in the cell, and is widely used for 





Gentamicin has four amine groups and is known as a cationic (positively charged) 
antibiotic141. The minimum inhibitory concentrat
approximately 2-5 µg/mL
µg/mL of gentamicin is applied to investigate the enhancement of the bioelectric effect 








E. coli treatment. The chemical structure of 
3.2.  
3.2: Chemical structure of the gentamicin140 
ion (MIC) of gentamicin for 
142. In the rest of the presented bioelectric effect studies, 10 
on.  
 
up was developed as shown in figure 3.3. 
 





Cuvettes (Invitrogen Inc., USA) with parallel electrodes forming two of the walls 
were used to apply a uniform electric field to the m dia inside of the cuvette. The cuvette 
is a widely used for biological researches particularly to transform bacterial cells which 
requires applying a high intensity electric field for a short period to insert a DNA stand or 
a protein into bacterial cells143. The metal electrodes provide an electric field directly 
inside of the cuvettes since the electrodes are exposed both the inside and outside of the 












Figure 3.3: Schematic of the cuvette setup used for bi electric effect experiments 
depicting suspension of the PyrexTM chips for biofilm formation between the two 
electrodes (spacing 4 mm). E  coli W3110 biofilms were pre-formed on the PyrexTM chip 
before treatments. PDMS is used to hold a PyrexTM chip upright providing a constant 
surface area for biofilm growth. Antibiotic (10 µg/mL of gentamicin) and Luria Broth 
(LB) growth media were placed in the cuvette, across which an electric field was applied. 
The width of the PyrexTM chip is smaller than the width of the cuvette, providing fluidic 








The setup for 6 parallel experiments was developed as shown in figure 3.4. A 500 µm 
thick PyrexTM wafer was diced into chips with dimensions 0.4 cm × 8.0 cm (width × 
length) and placed into cuvettes. A section of polydimethylsiloxane (PDMS) (prepared in 
a 10:1 ratio, base : curing agent) was placed into the cap of each cuvette, and was used to 
hold one PyrexTM chip upright between the two electrodes. Since the Pyrex is inert in 
biological solution and re-useable after biofilm cleaning via typically bleach, it was 
chosen to provide a constant area for biofilm growth. The PyrexTM chip was placed in the 
middle of the cuvette where the electric field is uniform. Biofilms were first grown on the 
PyrexTM chip in untreated bacterial growth media. The biofilm-coated PyrexTM chip was 
then transferred to a new cuvette with the same growth media but with an electric field of 
selected magnitude applied. The electrical signal was provided by a function generator 























3.1.4   Biofilm Experimental Procedures and Methods 
The overall experimental procedures are described in figure 3.5. E. coli W3110 
biofilms were formed on the PyrexTM chips for 24 hours in LB media at room 
temperature. The PyrexTM chips with matured biofilms were transferred to new sets of 
cuvettes containing 10 µg/mL of gentamicin in LB media. For bioelectric effect studies, 
electric fields were applied for 24 hours to the biofilm-containing cuvettes. Following 
treatments, both total biomass and viable cell densiti s of the remained biofilms on the 






Figure 3.5: Overall experimental procedure for bioelectric effect studies 
Quantification of remaining total biofilm on the chips was achieved by staining each 
chip for 15 minutes with 0.1 % crystal violet stain144. Each chip was gently immersed and 
rinsed sequentially in 4 prepared beakers of clean DI water to remove unbound crystal 
violet. After the chips were rinsed in DI water, the stained biofilms were resuspended in a 
1 mL solution of 80% ethanol and 20 % acetone for 30 minutes. The optical density 
(OD540) of the solution was measured by a spectrophotometer (Beckman Coulter Inc., 
USA). The final OD540 of the crystal violet released from biofilms corresponds to the 











In addition to the measuring total biomass, the viability of cells within the treated 
biofilms is a parameter indicative of the health/integrity of the remaining structure. 
Densities of vaiable cells in biofilms after various treatment were investigated using the 
colony forming unit (CFU) assay. The PyrexTM chips after treatments were vortexed for 
2-3 minutes in LB to remove and resuspend biofilms. Based on the OD600 of the solution, 
dilution ratios were selected for the assay. 20 µL of resuspended biofilm solution was 
plated on sterilized LB agar gel plates which were prepared with 25 g/L of LB and 15 g/L 
of agar. The plates were placed in an incubator ovenight at 37 °C. The density of live 
bacteria (CFU/mL) on each plate was calculated based on the number of CFU, dilution 
ratio, and original volume (20 µL) of the biofilm solution. Each experiment was repeated 
4 times (N = 4) and the results were averaged. The error in the results represents the 
standard deviation from the averaged live bacterial density. Three bioelectric effects are 
investigated. The AC bioelectric effect (AC-BE) is studied when 1.25 V/cm sinusoidal 
signal at 10 MHz is combined with 10 µg/mL of gentamicin. The DC bioelectric effect 
(DC-BE) is investigated by applying a 1.25 V/cm DC electric field with 10 µg/mL of 
gentamicin. The superpositioned bioelectric effect (SP-BE) is the combination of the 






3.1.5 Theoretical Representation of the Bioelectric Effect 
To investigate components of the SP-BE, I have developed a model of the 
independent effects of antibiotics and electric fields (Tantibiotic and Telectric field). The model 
was formulated based on an assumption that the total treatment efficacy (Ttotal) expressed 
log reduction of viable cell number, can be linearly decomposed into an antibiotic 
(Tantibiotic) component, an electric field (Telectric field) component, and a ‘synergistic’ effect 
(T*) based on the combination of the electric field and the antibiotic. The enhanced 
bioelectric effect (BE) is hypothesized to result from combining many previously 
observed bacteriocidal mechanisms associated with electric fields and antibiotics. Thus, a 
linear model of the BE can be an effective approach to quantify and analyze the treatment 
efficacy of different BEs. All variables of the equation in the model are defined here as 
the logarithmic reduction of viable biofilm bacterial density after treatments with respect 












T 10log            (12)
 
 
Therefore, the total BE (Ttotal) represents the sum of both the antibacterial agent (Tantibiotic) 
and electric field (Telectric field) effects alone, combined with the synergistic effect (T
*) of 





*TTTT eldelectricfiantibiotictotal ++=                                                    (13) 
 
Since the synergistic effect (T*) represents the enhanced treatment efficacy due to the 
combination of the antibiotic with the electric field, additional insight can be provided by 
investigating how different types of electric fields (i.e. DC, AC, and SP) produce 




SP). The treatment efficacies of 
antibiotics (Tantibiotic), applied electric field (Telectric field) and the total BE (Ttotal) were 
experimentally obtained using the CFU assay by quantifying the reduction of viable 
biofilm bacteria with respect to control experiments. Thus, three parameters in Eq. 13, 
Ttotal, Tantibiotic, and Telectric field, were experimentally obtained and the synergistic effect (T
*) 
was then calculated.  
This proposed equation can be further used as a first order theoretical model for 
independently investigating each parameter of the BE (Tantibiotic, Telectric field and T
*). These 
parameters may individually be functions of different variables. For instance, because the 
BE depends on the electrical energy provided by the ext rnally applied field, higher 
electric fields supply more electrical energy resulting in stronger antibacterial effects. 
Thus, each component of the model can be studied as an independent function 
represented by different variables, such as the duration of treatment with antibiotics or 
electric fields, the concentration of antibiotics, different types of antibiotics, the intensity 
of the electric fields and various combinations of AC and DC currents. The work 
presented here, based on the suggested model, can provide a mathematical framework for 
optimizing the bioelectric effect, as well as for understanding the relationships between 
the various treatments and hypothesized mechanisms (e.g., temperature, pH, oxygen, etc). 
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Hence, although the intensity and frequency of the SP electric fields were chosen based 
on avoiding media elecrtrolysis, the mathematical methodology may be useful to fully 
expand the range of various physical and biochemical inputs for analyzing their 
bacteriocidal effects. That is, one may investigate th  mechanistic basis for the 
synergistic effect quantification by examining different genetic backgrounds and other 







3.1.6 Experimental Results and Discussion 
The SP electric field imposes both a constant electrostatic force by the DC component 
and alternating electrical force due to the AC compnent. The SP field also provides 
more electrical energy than only that of either theAC or DC field without causing 
significant medium electrolysis. Supplying higher electrical energy for the BE 
corresponds to increasing the treatment efficacy. Therefore, the superpositioned 
bioelectric effect (SP-BE) was expected to result in an intensified treatment based on the 
presence of both high electrical energy and the individual mechanisms underpinning the 
effects of AC and DC fields.  
When a DC electric field is applied to a bacterial growth medium, however, there is a 
limit to the intensity of the applied potential (~ below 0.82 V) so as not to generate toxic 
byproducts through electrolysis of the media. To determine this limit, biomass 
quantification using crystal violet staining of biofilms was performed after application of 
different DC electric field intensities without gentamicin. The two electric field 
intensities investigated were 2 V/cm and 1.25 V/cm of DC electric field (corresponding 
0.5 V and 0.8 V respectively). 1 mL of E. coli suspension (OD600 = 0.20 – 0.25) was 
placed in each of the cuvettes. Two different intensities of electric signal were applied to 
the suspension separately for 24 hours. After DC electric fields were applied for 24 hours, 
the total biomass were quantified by the crystal vio et staining method. Hence, this study 
can provide efficacies of biofilm growth prevention without antibiotics even pre-biofilm 










Figure 3.6: Biomass quantification using crystal violet staining. The OD540 of the dye is 
proportional to the biomass. 
 
However, there was not an observed statistical difference in biomass growth between the 
two different electric field intensities (2 V/cm and 1.25 V/cm) as shown in the measured 
crystal violet OD540 (figure 3.6). Since the 2 V/cm intensity DC electric field (0.8 V over 
a 4 mm distance between two electrodes) induced electrolysis, 1.25 V/cm as the intensity 
of the DC electric field was selected to be used in later studies. The amplitude of the AC 
component of the SP electric field used in this work was the same as the intensity of the 
DC field. The frequency of the AC electric field was chosen based on the previous work67. 
Even though the intensity and frequency of the electric field were selected based on 
experimental results and literature, these parameters can be studied further to optimize 
the bioelectric effect with different combinations of the DC and AC electric fields.  
With the selected intensities of the electric field, total biomass reduction in different 























method.  The total biomass of E. coli biofilms was investigated following no treatment 
(no antibiotic or electric fields), antibiotic treatment (10 µg/mL of gentamicin), or 
application of the electric fields with the antibiotic. After 24 hours of E. coli biofilm 
growth, the biofilms were treated by four different methods for an additional 24 hours: 1) 
antibiotic treatment, 2) AC field with the antibiotic (AC-BE), 3) DC field with the 
antibiotic (DC-BE) and 4) SP field with the antibiotic (SP-BE). In figure.3.7, the biofilm 
density (OD540 after crystal violet staining) is depicted after various treatments. 
Gentamicin treatment had minimal effect relative to the untreated controls. Each applied 
electric field (DC and AC) resulted in 50% loss of biofilm due to the AC-BE and 46% 
reduction by the DC-BE. Interestingly, the SP field resulted in yet another 50% reduction  
compared to either AC-BE or DC-BE and ~73% overall (P < 0.05) relative to the 

































Figure 3.7: Total biomass quantification results using crystal violet staining after 
bioelectric effect (BE) treatment. In the superpositi ned (SP) BE, the minimum total 
biomass was measured compared to other treatments. The OD540 at SP-BE shows a ~71% 
decrease with respect to that of control experiments (Analysis of Variance (ANOVA), P 
< 0.05). The data is presented as the average OD540 with standard deviation over 6 
repeated experiments (N = 6 in each experiment). 
 
 
In addition to the overall biomass reduction due to the SP-BE, the viability of cells 
within the treated biofilms is a critical parameter indicative of the health/integrity of the 
remaining structure. The total treatment efficacy of each bioelectric effect is evaluated by 
the log reduction of live bacterial density based on the CFU density after biofilm 
treatment. The total treatment efficacy (Ttotal) was evaluated with separate experiments by 
applying either only gentamicin (Tantibiotics) or only an electric field (Telectric field) as 
described the method in the previous section of this c apter (3.1.4).  
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As shown in table 3.1 and figure 3.8, the decrease in the number of viable cells within 
biofilms following application of the SP field in conjunction with gentamicin (Ttotal = 2.6 
log reduction of viable bacteria) was 13 and 4.3 times greater than the reduction from the 
AC and DC fields with the same antibiotic (Ttotal = 0.2 and 0.6 reduction of logarithmic 
viable bacterial density, respectively). The synergistic treatment by the SP electric field 
(T*SP = 2.53) was shown to exhibit higher values than that of the AC (T
*
AC = 0.133) or 
DC (T*DC = 0.440) field treatments (19 and 5.6 times more reduction of viable cell 
density, respectively) as shown in Table 1C. By analyzing the effects of AC and DC 
fields, we found a synergy in reductions to biofilm viability beyond the sum of the effects 
of each field separately. The synergistic reduction of viable cells created by the SP field 
(T*SP = 2.53) was 4.4 times more than the sum of the effcts of the AC and DC fields 
(T*DC + T
*
AC = 0.573). Therefore, the combination of the DC and AC components in the 
superimposed electric field with gentamicin was not simply sum of two mechanisms, but 
is a rather complex function which induced a stronger synergistic effect that was absent 









Viable biofilm cells 
(CFU/mL)             
(average ± stdev) 
Log of viable biofilm 
cells (average ± stdev) 
Log reduction of 
viable biofilm cells 
(respect to control) 
Control 2.14×108 8.330 NA 
Gentamicin (1.95 ± 0.01)×108 8.290 ± 0.004 0.040 ± 0.004 
AC field (2.01 ± 0.02)×108 8.303 ± 0.008 0.027 ± 0.008 
DC field (1.62 ± 0.04)×108 8.210 ± 0.021 0.120 ± 0.021 
SP field (1.99 ± 0.01)×108 8.299 ± 0.004 0.031 ± 0.004 
AC-BE (1.39 ± 0.09) ×108 8.143 ± 0.056 0.20 ± 0.06 
DC-BE (5.69 ± 0.40)×107 7.755 ± 0.061 0.60 ± 0.06 
SP-BE (5.63 ± 0.40)×105 5.750 ± 0.062 2.60 ± 0.06 
 
Table 3.1 (a): Averaged viable cell densities and logarithmic values in untreated (control) 
and treated biofilms (N = 4 in each treatment). TheBE treatments applied were either the 
AC, DC, or SP fields with the gentamicin. 
 No electric field AC electric field DC electric field SP electric field 
No 
gentamicin 
N/A 0.027 ± 0.008 0.120 ± 0.021 0.031 ± 0.004 
Gentamicin 
(10 µg/mL) 
0.040 ± 0.004 0.20 ± 0.06 0.60 ± 0.06 2.60 ± 0.06 
 
Table 3.1 (b): Resulting bioelectric effect parameters (T values) following different 
treatments using results in table 1A (log reduction of viable bacterial density with respect 








 AC electric field (T*AC) DC electric field (T
*





0.133 0.440 2.53 
Table 3.1 (c): Synergistic effects in different BEs based on Eq. 2 and table 1(B) (log 













Figure 3.8: The total treatment efficacies of AC, DC and Superpositioned bioelectric 
effect. The treatment effects of gentamicin and electric field are evaluated in separate 





































The significantly greater reduction in total biomass and viable biofilm bacteria seen 
with the SP electric field (figure 3.7 and 3.8) can be attributed in part to the combined 
effect created by the increased electrophoretic and diffusion efficiency of the antibiotics 
due to the DC electric field along with the extracellular matrix polarization of biofilms 
generated by the AC electric field. That is, by inducing a high antibiotic concentration 
close to the biofilm surface and a strong gradient between the bulk fluid and the biofilm, 
electrophoresis and diffusion of the antibiotics through the biofilm are enhanced. Since 
gentamicin is cationic due to its four amine groups present in the molecular structure of 
the antibiotic, its local concentration is expected o vary under the influence of electric 
fields. We hypothesize that this may lead to spatially v ried antibiotic efficacy.  
To test this hypothesis we created a macroscale electrode system for analysis of 











Figure 3.9: Schematic of set up of gentamicin gradient studies. 100 µl of the solution is 
sampled with by a pipette and quantified by the Coomassie blue.  
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Coomassie blue dye shifts the absorbance peak of the gentamicin solution towards 595 
nm as the dye is reduced by the amine groups of gentamicin. Gentamicin was diluted 
with DI water to concentrations of 1, 10, 50, 100, and 1000 µg/ml for characterization of 
the reaction between Coomassie blue dye and gentamicin. 1 ml of Coomassie blue diluted 
ten times in DI water was added to 100 µl of gentamicin prepared in one of the three 
concentrations listed above. Following 5 minutes of incubation at room temperature, the 
OD595 of the solution was measured. The OD of the solution produced a linear relation 
from 1 to 50 µg/ml with the gentamicin concentration as shown in figure 3.10. The 
linearity of the OD changes with different concentrations of gentamicin confirms that 
Coomassie blue can be used for quantification of the gentamicin concentration. 
Additionally, compared to other antibiotic titrate methods, such as fluorescence145 or 
radioactive molecule labeling146 on antibiotics, this assay has advantages including a 
label-free system and direct correlation to the concentration of the agents. This newly 
developed assay can be used for the quantification of a tibiotic concentrations especially 






































Figure 3.10: The influence of the gentamicin concentration on the OD595nm of the 
gentamicin solution quantified by Coomassie blue dy. Results demonstrate linearly in 












Figure 3.11: Gentamicin was quantified by Coomassie blue dye. Normalized optical 
densities (OD595) in the parallel electrode chamber were measured under the effect of 
either an AC, DC, or superpositioned (SP) electric field. OD595 values are normalized 
with respect to the measured value at the cathode over 8 experiments (N = 8). Statistical 




Using this assay, the gentamicin distribution was measured under applied AC, DC, 
and SP electric fields for two hours. We evaluated gentamicin concentration at the 
indicated sample points (figure 3.11; C: cathode and A: anode). The OD595 at each 
location was normalized with respect to the OD595 at the cathode (C) as shown in figure 
3.11 since gentamicin is cationic (21). The SP electric field created statistically higher 
gentamicin concentrations at surfaces of  the electrode (anode: A) compared to the 
concentrations produced by the DC or AC electric fields alone; the average normalized 
concentration of gentamicin induced by the SP field was approximately 2.0 times that of 
the other fields at the anode (P < 0.05).  
The local concentration of a charged molecule is affected by the energy density of the 
external electric field. The electrical energy densitie  of DC, AC, and superimposed 
electric fields are calculated by equation 13 147, 
                              	








                 (14) 
where Wsuperpositioned is the electrical energy density [J/cm
3] of the superpositioned electric 
field, ε is the dielectric constant of the bacterial growth media [C/(V·cm)], WDC is the 
electrical energy density of the DC electric field, WAC is the electrical energy density of 
the AC electric field, T is the period of the electric field [s], and E is the intensity of 
electric field [V/cm].  Based on equation 4, the energy densities of the AC, DC, and 
superpositioned electric fields were 0.39ε, 0.78ε, and 1.17ε respectively. The 
superpositioned electric field provides an energy density that is 3 and 1.5 times higher 
than densities of the AC and DC electric fields respectively. The ODs in different electric 
fields are shown in figure 3.11. The SP electric field demonstrated a higher overall 
gentamicin concentration gradient than that imposed by a DC or AC electric field alone. 
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Although the normalized concentration gradient of gentamicin due to the SP electric field 
is not on the same order of magnitude as the synergistic effect, this high concentration 
gradient of the gentamicin enhances diffusion and the electrophoretic force on gentamicin 
into the biofilm, likely contributing to the strong synergistic effect. These results suggest 
that the generated concentration gradient may be one of the mechanisms contributing to 






Figure 3.12: Schematic of the proposed mechanism for the SP-BE biofilm treatment. (A) 
In the SP electric field application with the antibiotic, the measured steady state antibiotic 
concentration gradient (Fig. 4C) results in increased local antibiotic concentration close 
to the biofilm. (B) Since the SP electric field includes both DC and AC components, the 
antibiotic permeability of biofilm is enhanced as the AC field induces local vibration of 
charged molecules. This results in increased antibiotic diffusion and electrophoresis 
through the biofilm (red arrows indicate them). We propose the combination of the 
elevated antibiotic concentration proximate surface of biofilm with the high antibiotic 
permeability of biofilm results in the strong synergistic biofilm treatment efficacy (T*SP) 




Significantly improved treatment of biofilms was demonstrated by employing a 
superpositioned (SP) electric field in conjunction with an antibiotic. The SP bioelectric 
effect (SP-BE) was greater than the sum of the bioelectric effects of the DC and AC 
fields independently. Thus, the SP field enables a ynergistic effect that yields more 
bacteriocidal activity when both DC and AC fields are pplied. The enhanced treatment 
efficacy of the SP-BE might be due to both the previously described increased 
permeability of the membranes under the AC component and the apparent improved 
diffusion of the amine labeled antibiotics under the DC component. The intensity of the 
SP electric field utilized here was well below the el ctrolysis potential of the biological 
fluid. Hence, we envision applications of this technique that would minimize generating 
harmful radicals due to media electrolysis. Based on these enhanced biofilm inhibition 
efficacies as well as low intensity of electric field, the treatment method can be applied 






3.2 Electrolysis of the Bioelectric Effect 
3.2.1 Overview of the Experiment 
Biofilm treatment was performed by applying an electrical signal with antibiotics 
based on the principles of the bioelectric effect as described section 3.1. The key 
consideration of the bioelectric effect in this work was utilizing the method with a 
biocompatible electrical signal that is below the treshold potential of media electrolysis 
(0.82 V at 25 °C in pH 7)65. The electric voltage is characterized with 0.5 V for the 
conventional cuvette setup that is lower than the thr shold of medium electrolysis.  
Even if the voltage was below the threshold, quantit tive studies of the electrolysis 
effect of each electric field (AC, DC and SP fields) were conducted by measuring pH 
changes using a pH indicator (#36828, Fluka Analytical) which actively reacts at pH 4 – 
10. Optical density characterization of the indicator was performed with 1 mL of 
phosphate buffer (pH 5, 7, 8) and measured the absorbance spectrum from 500 nm to 700 
nm by a spectrophotometer (Evolution 60, Thermo Scientif c Inc.). In this work, the 
cuvette setup was utilized to apply for electric fields as well as measure OD values 
















Figure 3.13: A photo of the cuvette setup for electrolysis quantification. The electric field 
was applied for 24 hours continuously to the bacterial g owth media (LB). Changes of pH 
were quantified by a pH indicator.  
 
A 1 mL of bacterial growth media (LB) was placed in sterilized cuvettes and applied 
either 0.5 V amplitude sinusoidal signal at 10 MHz (AC), 0.5 V DC, or SP-field (AC+DC) 
for the media by a function generator and DC power supply for 24 hours. Then, the pH 
indicator was added to the solution and measured a specific wavelength optical densities 
(OD616) based on the initial wavelength scan result (figure 3.14 and 3.15). Each 
experiment was repeated three times and presented a average value with their standard 
deviations (figure 3.16).  
 
 
3.2.2 Electrolysis Quantification Results 
Since electrolysis of the media involves hydrogen gas eneration resulting in decreased 










basic due to the electrolysis. Using a pH 8 buffer solution, a strong absorbance peak was 
shown at a wavelength of 616 nm (OD616) (figure 3.15).  Thus, the electrolysis effect was 
quantified by measuring the OD616 after applying electric fields. After applied each field 








Figure 3.14: Demonstration of color changes of the pH indicator in known pH solutions 
using a phosphate buffer solution. The pH 8 color was referred to quantify electrolysis 
effects.  
 




Figure 3.15: Representative OD616 spectrum between 500 nm and 700 nm by a 
spectrophotometer (Evolution 60, Thermo Scientific In .). Since the peak value from pH 
8 buffer solution using a pH indicator was observed at 616 nm wavelength, OD616 was 
selected to quantify the electrolysis effect from different field applications. Only the 820 









Figure 3.16: OD616 values in each experiment. The AC electrical signal w s 0.5 V 
amplitude of sinusoidal signal at 10 MHz and the DC was 0.5 V magnitude. The SP-field 
was combination of the AC and DC fields. A 0.82 V of DC was also applied separated as 
a control experiment of the electrolysis threshold t  the media. The experiments were 
repeated three times, the averages and standard deviations are presented. We conclude 
that SP field is not due to electrolysis of the growth media. 
 
The results show the SP field was not induced significa t electrolysis due to the electrical 
energy supply. Compared to the threshold of the electrolysis (820 mV DC), the SP-field 
was shown a minimal pH change (less than 0.05 changes of pH). Therefore, this 
concludes that the SP-field does not induce massive electrochemical condition changes in 






Biocidal effect of radicals due to electrolysis is significant side-effect to apply 
bioelectric effect to clinical fields. In this thesis work, by superpositioning AC and DC 
field, the required voltage was reduced below the tr shold of the biological media 
electrolysis. Moreover, the treatment efficacy in both traditional cuvette setup and 
microfluidic environment was significant compared to the only antibiotic treatment. With 
this quantification of the pH changes in the field application, the biocidal effect of the SP 
field was studied and demonstrated that it does not induce major media electrochemical 
decomposition. Based on this result, significantly improved biofilm treatment efficacies 
as shown in the previous work (section 1.4.4) were possibly due to the simultaneous 
introduction of the AC and DC field rather than enha cement of electrochemical 
environmental modifications. The AC field can induce local molecular vibration of the 
partially charged cell proteins67, 114 and DC field can improve electrophoresis of the 
biofilm based on the consistent electrostatic force64, 114. When these two mechanisms are 
applied in parallel, the biofilm treatment can be significantly improved. Perhaps more 
importantly, it is believed that this result encourages to apply this method for clinical 
biofilm management since this method does not cause massive harmful radical generation.  
However, this quantification of electrolysis is focused on evaluating the bulk impacts 
of the electrolysis rather than local investigation. Even if a major electrolysis was not 
observed by the SP field application, local electroly e distribution of the media can be 
varied due to the electrostatic energy supply from the SP field. This spatiotemporal 
critical electrolyte investigation when the field was applied can provide for fundamental 
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scientific information of the bacterial metabolic reactions in the condition as well as 





3.3 On-Chip Demonstration of the Bioelectric Effect 
 
Integration of bioelectric effect with a microdevice makes the concept of biofilm 
treatment enable to apply for biomedical applications. Although the bioelectric effect has 
been demonstrated by many groups62, 63, 64, 66, 114, on-chip validation of the effect has 
never been investigated. Scaling of the SP-BE to the micro-scale is a critical requirement 
in realizing the SP-BE for in-vivo and in-vitro biofilm infection management, as the 
scaling of the treatment to smaller dimensions enabl s the SP-BE to utilize further 
biocompatible parameters, including voltage requirements. 
Based on advantages of the microfluidic platform (i.e. small volume of samples, 
consistent environmental control, multi-parallel exp riments, and compatible to the 
integration with other MEMS devices)149, 150, a bioelectric effect integrated microfluidic 
device has been developed. The intensity of the electric field and concentration of 
gentamicin are the same as the previous superpositioned bioelectric effect studies.  
Finally, I would like to acknowledge Mr. Matthew Mosteller in collaboration of this 
specific work that he contributed to developing the system significantly. 
 
 
3.3.1 Principles of Operation 
Here, optical density (OD) based microfluidic system was developed based on the 
advantages of low sample and precisely controlled environment for biofilms. The OD 
values are directly correlated with the total biomass141. For real-time OD measurement, 
linearly integrated charge-coupled-devices (CCDs) are aligned under the microfluidic 










Figure 3.17: Schematic of the optical density measurement of the biofilms. 
 












As biofilms are grown thicker and thicker, the transmitted light intensity is changed 
corresponding to the total biomass changes. In the microsystem development, a light-
emitting diode (LED) light is introduced over the platform continuously which provides 
nearly uniform illumination intensity over the whole platform. Transmitted light through 
the channel is monitored by optical absorbance in the CCDs.  
 
3.3.2 Planar Electrodes for the Bioelectric Effect 
To integrate the bioelectric effect to a microsystem, fabrication of electrodes is 
required. However, a planar electrode induces spatial non-uniformly distributed electric 
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field based on changes of the electrostatic force (Columb’s law) as the distance is 
changed between the charge location and measured position inside of the reactor. 
Investigation of the non-uniformity of the field is critical since this spatial gradient of the 
field creates a dielectrophoretic force to charged molecules. For instance, in this work the 
antibiotic gentamicin is positively charged along with diverse electrolytes in the growth 
media. Therefore, distribution of the antibiotic can be varied due to the induced 
dielectrophoretic force. The non-uniform antimicrobial agent to biofilms is also known as 
a biocidal effect151. This additional condition can be challenged to analysis the efficacies 
of the bioelectric effect. Based on this consideration, numerical analysis of the electric 
field distribution in a relevant microfluidic reactor was performed focusing on the 
quantification of the dielectrophoretic force via the thin planar electrodes.  
The calculation was focused on the variation of the int nsity of the field from the 
bottom to the top layers of the microfluidic channel. Since the electrode was assumed as a 
submicron thickness of electrodes, non-uniform electric field distribution was expected 
since the intensity of electrostatic force is depended on the distance from the charge to 















Figure 3.18: An example of non-uniform electric field distribution demonstrated via 
COMSOL simulation.  
 
This spatial non-uniformity of the electric field induces a dielectrophoretic force that can 
create a gradient of charged molecules and non-uniform distribution of electrolytes along 
the direction of the force152. Since some antibiotics including gentamicin have partial 
charges153, this dielectrophoretic force induction can cause changes of drug distribution 
over biofilm growth reactor that can affect to treament efficacy of the method due to the 
local antibiotic concentration differences143. The dielectrophoretic force was proportional 
to the value of differentiated square of the electric field. The numerical analysis result is 










































Figure 3.19: The intensity changes from the bottom  top of the microfluidic channel. 
The difference of the electric field was within 0.01 V/cm ranges which is not induced 
significant dielectrophoretic force.  
 
As shown in the result, the variation of the intensity was not significant along the z-axis 
channel. The maximum difference between the top and bottom was approximately 0.001 
V/cm which corresponds to ~ 10-24 N dielectrophoretic force143. This is not a significant 
force induction that enables local changes of the antibiotic gentamicin considering its 
density.  
Based on this numerical analysis, it was concluded that the planar thin electrodes to 
supply electric field in the microfluidic chamber for biofilm treatments was not induced 
significant non-uniformity of the electric field. The calculated non-uniformity of the field 
expected to create a minimal dielectrophoretic force. Therefore, a conventional thin metal 




The parallel electrodes for the bioelectric effect were patterned on either side of the 
SAW sensing area (schematic is shown in figure 3.21). After the sensor fabrication 
presented in section 3.1.1, electrodes to apply for electric fields was patterned by 
photolithography. Cr/Au (15 nm / 200 nm) was deposited by an evaporation and lift-off 
as demonstrated in the previous on-chip bioelectric effect experiments (in section 2.6.1). 
The width of electrode was 2 mm for electric contacts of the power source.  
 
3.3.3 Design and Fabrication of the Microfluidic System 
The platform is consisting of electronics with linear array charge-coupled devices 
(CCD) and supporting electrical components, a microfabricated patterned base, and 
molded microfluidics. CCDs (TSL202R, Texas Advanced Optoelectronic Solutions) used 
for optical density (OD) detection are integrated on a custom printed circuit board (PCB, 
Advanced Circuits) to enable six parallel experiments on a single chip measuring 9.5 cm 
× 8.1 cm.  The CCDs feature 128 × 1 linear photopixel arrays154.  
A 500 µm-thick PyrexTM wafer serves as a transparent substrate for the paterned base. 
Gold electrodes patterned on the substrate provide electric fields required to induce the 
SP-BE, while simultaneously limiting peripheral light from entering the CCD 
components. The electrodes (Cr/Au 15 nm / 200 nm), fabricated by physical vapor 
deposition on top of photoresist (AZ-5214, MicroChemicals GmbH) followed by liftoff, 
feature 2 mm spacing within the microchannels.  
Molded microfluidic structures are fabricated through a standard 
polydimethylsiloxane (PDMS) process. Reversible bonding of the PDMS channel to the 
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patterned substrate is achieved by applying methanol to the PDMS, then aligning and 
placing it onto the PyrexTM chip. The resulting microfluidic chambers measure 100 µm 
deep, 2 mm wide, and 1.75 cm long for a total chamber volume of 3.5 µL. The 
microfluidic chamber is integrated with an external syringe pump (Cole Parmer 74900) 
operating in withdrawal mode to minimize device leakage.   
Actuation of the CCD devices in the Micro-BOAT platform requires a power source, 
drive clock, and serial input bit provided by an external power supply (Agilent E3631A) 
and accompanying function generators (BK Precision 4040). Signal readout from the 
CCDs is achieved using a data acquisition device (NI USB-6221, National Instruments). 
All external electrical signals are integrated with the Micro-BOAT platform via wire-to-
board connectors (Molex Connector Corporation) and BNC cables (L-Com Global 
Connectivity). Illumination of the Micro-BOAT system for OD measurement is achieved 
using a diffusive edge-lit LED light panel to provide uniform illumination of the system 
(Luminous Film USA). Light emission is tuned to a wvelength spectrum centered at 630 
nm by a polycarbonate lighting gel film (Roscolux #120, Rosco Laboratories) in order to 
match the peak sensitivity of the CCD components. The entire assembly is placed within 



















Figure 3.20: Schematic of the microfluidic biofilm observation, analysis and treatment 
(Micro-BOAT) platform used for the demonstration of the superpositioned bioelectric 
effect (SP-BE). Microfluidic channels serving as biofilm growth reactors are fabricated 
from polydimethylsiloxane (PDMS) and bonded on a transparent PyrexTM substrate to 
enable optical density (OD) measurement. The platform is capable of performing 6 
experiments in parallel on a single chip. Real-time biofilm monitoring is achieved via the 
measurement of biofilm OD using charge-coupled devices (CCD) and a tuned light 










Figure 3.21: Schematic of the SP-BE biofilm treatment, which uses 200 nm thick planar 
electrodes spaced 2 mm across the 100 µm deep microfluidic channel to emit a SP 
electric field comprising a 10 MHz AC signal at 1.25 V/cm (corresponding to 0.25 V for 
2 mm electrode spacing) with a 1.25 V/cm DC offset. Electrodes are exposed by 0.25 mm 
on each side of the microfluidic channels to expose th  electrodes directly to the 
microfluidic channel. AC electric fields increase biofilm permeability, allowing for 
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greater antibiotic penetration into biofilms, while a DC electric field component induces 
localized non-uniform electrolyte distributions. The combination of the SP electric field 
with antibiotics (10 µg/mL of gentamicin) demonstrates significantly improved biofilm 
treatment efficacy due to the synergistic effect of the AC and DC BE. 
3.3.4 Experimental Procedures 
The demonstration of the superpositioned bioelectric effect in a micro-scale device 
has been achieved using the Micro-BOAT platform. Bacterial cultures of Escherichia coli  
BL21 pGFP are grown in Lysogeny Broth (LB) media to an OD600 of 0.25 AU. Testing is 
performed by initially inoculating a microfluidic chamber with bacterial suspension for 2 
hours at 37°C with no flow to allow microbial attachment to occur on the channel 
substrate. LB media is then flowed continuously through the channel for 24 hours at 
20µL/h by a syringe pump (Cole-Parmer Instrument Company, USA) to replenish 
nutrients and foster biofilm growth.  For the channel dimensions presented here, this 
equates to an effective flow velocity of 30µm/s and has been optimized to provide an 
environment conducive to biofilm growth.  Following the 24 hour growth period, four 
treatments are performed on the mature biofilms: control (no antibiotic or electric field 
applied), only superpositioned electric field, only gentamicin, and the enhanced 
bioelectric effect (superpositioned electric field with gentamicin). Control biofilms are 
continuously provided LB media at the same flow rate in order to determine steady-state 
biofilm growth. Biofilms treated with gentamicin, both in antibiotic-only experiments and 
those featuring the enhanced bioelectric effect, are done so with a 10 µg/mL 
concentration of the drug. The electric field featured in the biofilm experiments was 
introduced by a function generator (Agilent Inc., USA). Each of the four biofilm 
treatments is conducted with 3 experiment samples to demonstrate repeatability of the 
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various assays.   
Optical density measurements are taken non-invasively n real-time with respect to 
both average OD change as well as localized morphology. Measurements are obtained 
every 8 minutes from the CCD devices to monitor the spatiotemporal development of the 
bacterial biofilms beginning after the initial two-hour inoculation period. Additionally, 
bacterial cell viability staining and fluorescence microscopy is used to provide end-point 
analyses of cell viability within the biofilms to verify treatment efficacy. Since the strain 
of bacteria used (BL21 pGFP) fluoresces green when t  bacteria are metabolically 
active, only propidium iodide (PI) (Invitrogen Inc., USA) is needed to stain dead bacteria 
allowing them to fluoresce red. Following biofilm treatments, the microfluidic chamber is 
initially rinsed with phosphate buffered saline (PBS) solution at a rate of 200 µL/h for one 
hour to quantify only adherent bacteria. The stain is then supplied at a concentration of 
1.5µL PI per 1000µL PBS at a flow rate of 200 µL/h for an additional 2 hours and 
unabsorbed stain rinsed from the microchannel using PBS at the same flow rate for an 
additional one hour. The ratios of live bacteria surface coverage with respect to the total 
biomass surface coverage for different treatments are analyzed using the software 
package ImageJ (Image J 1.44, USA). For each experiment, both optical density and 







3.3.5 Results and Discussion 
Four separate experiments are performed simultaneously: control (no electric field or 
antibiotic), only superimposed electric field, only gentamicin and superpositioned 
bioelectric effect (gentamicin with the superimposed electric field). The overall biomass 
monitoring is achieved by the CCDs. In addition, the density of viable bacterial cells is 
investigated using live/dead cell staining at the end of the treatment.  
Changes of OD during treatments are presented in figure 3.22. The results show more 
decrease OD in the superpositioned bioelectric effect than that in other treatments. It is 
for the first time the superpositioned bioelectric effect demonstrates effective treatment of 
biofilm compared to the only antibiotic treatment i a microfluidic device. At the end, 
biofilms treated by the superpositioned bioelectric effect showed a 40% decrease in OD 
respect to the beginning of treatments which implied substantial biomass decrease155, 

































































Figure 3.22: Measured changes in OD during biofilm treatment using the microfluidic 
optical platform.  Each curve represents the average OD change for three samples with 





After treatment, the biofilm in the microfluidic channel is stained using live/dead 
fluorescent dye (Invitrogen Inc., USA) to investigae the treatment efficacy of the 
bioelectric effect. Using a fluorescent microscope (Olympus BX60), biofilm images are 
obtained (figure 3.24). The optical coverage of the images is evaluated using an image 
processing program (Image J) respect to the live and dead cell fluorescence surface 
coverage. The quantified viability of bacterial cell density is presented in figure 3.25.  
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Figure 3.23: Relative changes of biomass after treatm nts in the microfluidic channel. 



























Figure 3.24: Representative fluorescence microscopy images of biofilms in the Micro
BOAT channels following maturation and treatment. The total biomass fluorescence 
images (left column) and viable biomass fluorescence (right column) of biofilms show 
control (A and E), SP electric field (B and F), traditional antibiotic (C and G), and SP
(D and H) treated biofilms. Biofilms treated with the SP
as well as low viable bacterial cell density (H). Seven fluorescence images were taken for 












































Figure 3.25: The percentage of viable biofilm bacteria with respect to total biomass after 
each treatment is calculated using image processing software (Image J 1.44). The results 
include the average of seven image analyses (N=7) for each of the four treatment 
methods. Viable cell percentages and standard deviations are obtained with respect to 
total fluorescent mass surface coverage using a binary image conversion (see the 
Methods). The density of non
increase 56% in comparison to treatments using antibiotics independently (P = 0.019)
 
 
The biofilm treated with the superpositioned bioelectric effect shows a 56% decrease in 
bacterial viability compared to antibiotic treatmen
As shown in data, the superpositioned bioelectric effect has been demonstrated for the 
first time in a microfluidic pla
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30.   
-viable cells in biofilms treated by the SP
t alone.  
tform. The on-chip bioelectric effect showed a 40% 




decrease in overall biomass as well as 56% improved treatment efficacy compared to 
only antibiotic treatment based on the cell viability studies.  
Validation of the SP-BE using thin-film planar electrodes in a micro-scale 
environment represents a critical step in the development of SP-BE treatments for future 
clinical applications.  The reported levels of efficacy are statistically significant (P < 0.05, 
figure 3.25) and support the use of thin planar electrodes to induce the SP-BE, with the 
current Micro-BOAT system demonstrating efficient treatment in a microfluidic system 
that is 500 times deeper than the thickness of the electrodes (0.2 µm thin-film gold 
electrodes in a 100 µm deep channel) . The use of thin-film electrodes to induce SP 
electric fields enables the scaling of treatment sys ems utilizing the SP-BE to sub-micron 
thicknesses while maintaining broad effective treatment areas. Such a method provides a 
potential approach for localized infection treatments that require reduced antibiotic 







In this chapter, a new effective biofilm treatment technique was presented by 
combining a superpositioned electric field with antibiotic gentamicin. The method is 
utilized electric potential required even below the threshold of electrolysis of the 
biological fluid. This is critical to apply the bioelectric effect to clinical applications since 
generation of hazard radical ion can be minimized.  More importantly, the 
superpositioned bioelectric effect (SP-BE) demonstrated significantly enhanced biofilm 
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reduction compared to the only antibiotic treated samples. The SP-BE was further 
demonstrated in a micro-scale device. Based on the low voltage requirement and 
significant biofilm inhibition in a microdevice, this technology can be further developed 





Chapter 4: Integration of the Sensors with the Bioel ctric Effect 
4.1 Design of the System 
Since the acoustic waves are induced by an electrical actuation on the piezoelectric 
material, the integration of the electric field for the biofilm treatment can cause 
attenuation of the wave propagation due to the proximity of the applied field for biofilm 
treatment to the SAWs. In addition to the potential electric field interference between the 
sensor and bioelectric effect, the microfluidic flow can affect to the SAW propagation 
since the flow induces surface friction that may result in changes of the SAW velocity. 
The initial speed shift of the waves will result in a decrease of the sensitivity and require 
calibration each time which can impact to the reliabi ty of the sensor operations. 
 
4.1.1 Electric Interference between the Sensor and Bioelectric Effect 
The investigation of the electrical signal interference to the SAWs was conducted 
with a device geometry shown in figure 2.37. The Al2O3 film deposited on the ZnO layer 
and the electrodes for the bioelectric effect were fabricated with air gap in each side. The 
induced field intensity on the ZnO layer due to thevoltage (0.25 V of DC + 0.25 V 
sinusoidal signal at 10 MHz) applied for the biofilm treatment was calculated based on 
the electromagnetic theory (Maxwell’s equation)156. The derived equation for the ZnO 
layer is presented in equation 15.  
The dielectric constant of each layer indicates the characteristics of the polarity of the 
medium that directly corresponds to the induced electric field intensity. Using Maxwell’s 



































Figure 4.1: Schematic of the device cross-section for electric field distribution analysis. 
The ZnO can affected by the voltage applied for the bio lectric effect during the biofilm 
treatment. The simulation was focused on the ZnO layer from X2 to X3 locations. ɛ 
represents a dielectric constant of the each medium. 
 
 
                                                                                                                               (15) 
 
where Q is total charge on the metal electrode (at position 0), A is the surface area of the 
electrode, Ctotal is overall capacity of the system, V0 is the magnitude of the applied 
voltage (0.25 V) and ɛ0 is the dielectric constant of air (vacuum). Using the current 
device design parameters, such as thickness and width of ZnO, Al2O3, electrode and air 
gap distance, the intensity of the electric field was calculated.  
 
                                                                                                           (16) 
 
Based on the obtained value, the induced displacement of ZnO was estimated based on its 
piezoelectric coefficient, which was obtainedfrom literature157 . The derivation is 
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Through the calculation, the induced displacement is in thefemto-meter scale. 
Considering the wavelength (12 µm: twice of the displacement of the acoustic wave), the 
induced attenuation of the SAW is six orders of magnitude smaller than the wavelength 
displacement. Therefore, a potential cross-talk betwe n the SAW and the bioelectric 










S: strain due to the applied E-field 
d: piezoelectric strain coefficient (C/N) 
E: electric field (V/m) 
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4.1.2 Shear Stress of the Flow on the SAW Sensor 
 The microfluidic flow shear effect to the SAW propagation was investigated 
based on the physics of the laminar microfluidic flow conditions. The schematic of the 














Figure 4.2: Schematic of the laminar flow on the SAW. The theoretical analysis was 
focused on the impact of the SAW speed changes due to th  flow. 
First, the Reynolds number was calculated to ensure that theflow in the channel is 
laminar. The dimension of the microchannel was taken from the previous microfluidic 
bioelectric effect demonstration device (100µm heigt, 2mm width and 2cm length). The 
Reynolds number158 was found to be ~ 4.2 which is less than the threshold of laminar 
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Figure 4.3: Schematic of the laminar flow at the microchannel. The velocity profile is 
related with the geometry of the channel (i.e. heigt)133. 
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The shear surface tension on the substrate is known t  be proportional to the velocity 
profile of the laminar flow. The derived velocity slope is shown in equation (18). In 
addition, the surface tension on the SAW is calculated based on the changes of SAW 
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With relevant values of the parameters, the changes in the speed of the SAW due to the 
fluidic flow were approximately 10-7 m/s which corresponds to a 0.078 Hz resonant 
frequency shift. Since the resolution of the network analyzer (HP8510B) for monitoring 
of the SAW sensor when biofilms are treated or grown is 0.1 Hz, it is concluded that the 
microfluidic flow does not cause significant impact to SAW resonant frequency 
monitoring.  
∆t: time to propagate a wavelength (1/f) 
d
ZnO
: thickness of ZnO 
µ: dynamic viscosity of water  







: maximum flow rate (2 x 4.2 x 10
-2
 m/s)  
h: height of channel (100 µm) 
λ: wavelength of SAW (12 µm) 
u
s
: speed of SAW (4812m/s) 
ρ
ZnO





: thickness of ZnO (400 nm) 
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 Through the numerical analysis to investigate potential integration challenges, the 
SAW sensor is expected to work properly in an integrated system with the bioelectric 
effect as an independent sensor demonstrated previously.  
 
4.1.3    Overview of the Integrated System 
The integrated microsystem was designed for real-time biofilm detection as well as 
effective treatment with low doses of antibiotics. The integration of the biofilm sensor 
with a treatment method is critical to manage biofilm associated infectious diseases 
systematically. The sensor provides a means to measur  the total amount of the biofilms 
which acts as a feedback signal to the system to determine treatment methods. Moreover, 
the progress of the biofilm treatment is also monitored by the sensor. Through this 
systematic approach, biofilm management can be significa tly more effective as the 
system detects the on-set of biofilm formation and subsequently provides the intensified 
inhibition of the biofilms. The integrated microsystem is composed of the SAW sensor 
for real-time biofilm detection and the superpositined bioelectric effect.  
The bioelectric effect has a unique capability for integration with a micro-scale device. 
To induce the effect, an electric field has to be applied through an electric potential 
between separated electrodes. The electric field (E) between two uniformly separated 
electrodes is defined by equation (21)127, 
E=V/d                                                      (21) 
where V is the applied electric potential, d is the distance between the two electrodes, and 
E is the intensity of the electric field. Based on equation 1, a key requirement for 
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integration of the bioelectric effect with a microsystem is the induction of electric 
potential. Since the distance between the two electrodes (d) can be in the micro-scale in a 
microfabricated device, the electric potential can be significantly decreased. For example, 
a voltage of 1 V over a 1cm distance between electrodes is required to induce an 1 V/cm 
electric field intensity. However, when the distance between the electrodes is 10 µm, the 
electric potential is decreased to 1 mV which is more biocompatible than the intensity of 
the electric potential in a macro-scale device. By decreasing the intensity, the electric 
field for bioelectric effect can be implemented foruture in-vivo applications. Therefore, 
the bioelectric effect integrated with a micro-scale device has a significant advantage 
over macro-scale devices in improving the antibiotic treatment efficacy on biofilms. 
Furthermore, by decreasing the magnitude of the electric field in the microsystem, the 
bioelectric effect can be used for clinical applications.  
The schematic of the SAW sensor and bioelectric effect integrated microsystem is 
shown in figure 4.4. The SAW sensor is fabricated on a silicon wafer with a deposited 
thin layer of piezoelectric ZnO. The dimensions of the sensor are approximately 1mm by 
3mm with a thickness of 0.5 mm. The electrodes for inducing the bioelectric effect are 
fabricated by metal evaporation after photolithography. The electrodes can also be 
extended to cover a wide area for biofilm treatment while maintaining the intensity of the 
electric field. Finally, a polydimethylsiloxane (PDMS) chamber is integrated over the 
















Figure 4.4: Schematic of the integrated microsystem of the SAW sensor and electrodes 
for induction of the bioelectric effect. A microfluidic chamber is integrated over the 




In the design of the integrated microsystem for both continuous biofilm detection and 
enhanced biofilm treatment, clinical applications for biofilm management were 
significantly considered. The SAW sensor was designed based on the biocompatibility of 
the material and minimizing the sensitivity loss when the sensor is passivated by a thin 
film to prevent degradation of the key material of the ZnO layer. Through theoretical 
modeling of the sensitivity, an appropriate material for the passivation film was chosen. 
The Love mode of SAW was designed to achieve a highly sensitive biosensor. The 
overall dimension of the sensor was compatible for future in-vivo applications (3 mm of 
width, 1 mm of length and 0.5 mm of the thickness). The treatment method was 
developed based on the bioelectric effect which increases biofilm treatment efficacy as 
combined electrical signals with antibiotics. To reduce the high voltage requirement that 
is limited by the electrolysis potential (0.82 V), a superposition of the AC and DC fields 
is designed. The intensity of the field is required a lower voltage than the threshold. 
Fabrication of two electrodes along with the SAW sensor allows to impose electrical 
signals to the biofilm. Biofilm growth is localized as a microchannel fabricated by PDMS 
is assembled over the system. This system is expected to provide the total presence of 







In the fabrication of the integrated device, two prcesses are particularly critical to 
achieve highly sensitive and reliable operation of the system. These are the pulsed laser 
deposition (PLD) for the ZnO film growth and atomic layer deposition (ALD) for Al2O3 
film fabrication. PLD provides the highest ZnO quality with extremely low concentration 
of impurities. The process is relatively simple and the orientation of the ZnO is well 
controlled due to the high stochastic correlation with the crystal structure of target 
material160. Based on the high quality and single crystal film fabrication advantages, the 
PLD was chosen to deposit the piezoelectric ZnO film (500 nm) for this system 
development. ALD can control the thickness of the film rom a single to thousand atomic 
layers of the material which is critical to fabricate precise and robust microelectronic 
systems at a low temperature (~ 150 ºC). The ALD was utilized in this work for 
fabrication of a passivation layer for long term reliable operation of the device in 
bacterial growth media13.  
A 60 nm silicon dioxide (SiO2) layer was deposited on (100) Si substrates by low 
pressure chemical vapor deposition (LPCVD) to prevent acoustic wave loss to silicon 
substrate. The IDT was patterned using traditional photolithography before depositing the 
ZnO film. Cr/Au (15 nm / 200 nm) as the IDT material was deposited on the wafer by 
electron-beam evaporation, followed by lift-off. The wafer was diced and crystalline (001) 
orientation ZnO (c-axis oriented ZnO) films on SiO2/(100)Si substrates were grown by 
PLD. The laser deposition system used a KrF excimer laser at a wavelength of 248 nm 
with pulse duration of 25 ns to ablate a high purity (99.999 %) ZnO ceramic target. The 
ZnO layer was grown at 300 °C with an ambient oxygen partial pressure of ~1.0×10-4 
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Torr. After ZnO film deposition, the ZnO was pattern d using a solution that consisted of 
phosphoric acid, acetic acid, and deionized water (1:1:30) with photoresist mask. The 
device was annealed at 800 °C for one hour to increase the resistivity of the ZnO161. 
Finally, the ZnO surface of the SAW sensor was coated by depositing a 100 nm thickness 
Al 2O3 film using atomic layer deposition (ALD) at 150 °C
162.   
A polydimethylsiloxane (PDMS) chamber was assembled to the fabricated chip to 
provide a constant supply of fresh bacterial growth media and the antibiotic. The PDMS 
has advantages for biofilm research based on the air permeability, low-cost and ease 
fabrication process163. A mold of the microfluidic structures was fabricated by patterning 
100 µm–thick KMPR-1050 on a silicon substrate using contact photolithography. PDMS 
(Sylgard 184, Dow Corning) in a 10:1 ratio was then poured over the mold and cured in a 
furnace for 20 minutes at 80 °C16. After cooling, the PDMS was removed from the mold 
and cut to fit the fabricated device. The bonding between the microfluidic channel and 
the device was reversible using methanol to treat the PDMS layer. A schematic of the 




























Figure 4.5: Overall schematic process flow. (a) 60 nm PECVD SiO2 deposition and 
interdigitated electrode pattern and deposition (Au) by an electron beam evaporation, (b) 
500 nm ZnO deposition using pulsed laser deposition, (c) ZnO patterning using weak 
acid etchant (1:1:30 ratio of acetic acid: phosphoric acid: deionized water), (d) 100 nm 
thickness of ALD Al2O3 deposition at 150 C, (e) Electrode patterning and f brication via 
Au evaporation (Cr/Au, 15 nm/200 nm) and (f) PDMS microchannel assemble. (g) Photo 
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4.3 Testing Setup 
Design of a parallel experimental setup is critical to achieve the high throughput that 
is needed to investigate the variation of biofilm growth with statistical significance164. 
Moreover, since bacterial biofilms growth is stochastic, conducting experiments in 
parallel with the same condition is critical to reduce statistical variations in each 
experiment. A multiplex logic circuit was implementd to conduct four parallel biofilm 
experiments simultaneously to overcome a single channel network analyzer to monitor 
resonant frequency of the system. Depending on the multiplexing bits, it is possible to 






Figure 4.7: Flow chart of the switching setup. With this circuit integration, four sensors 
were tested at the same time for biofilm growth andtreatment experiments. 
 
In this setup development, a 4 bit multiplexer is used to perform four parallel experiments: 
control, electric field only, antibiotic only, and combination of the antibiotic with the 
electric field. The temperature was controlled to be 37 °C by a hotplate27. To localize the 
biofilm growth in the biofilm sensing area where the SAWs propagates between input 














and output of the IDT, a microfluidic channel was as embled over the device. In addition, 
fresh bacterial growth media and antibiotics were povided to the microchannel by an 
external syringe pump with a constant flow rate (20 µL/h). The resonant frequency of the 
SAW sensor was continuously monitored by a network analyzer and recorded by the 
computer through the general purpose interface bus (GPIB) communication. For 
application of electric field to the biofilms, an ext rnal power source (Agilent Inc., 3320A) 
was connected to the setup for 24 hours. Finally, electric contacts between the device and 
external equipment were properly achieved by a spring loaded pin on each contact. The 
overall electric data flow chart is shown in figure 4.7. 
The multiplexer (MC74HC4052N, Motorola Inc.) was switched by 4 bit counter 




Table 4.1: Binary code of the counter for each sensor 
 
Figure 4.8 shows the designed electronic board for the parallel experiments. The electric 
contacts between the board and the device are achieved by using spring loaded pins as 
shown in figure 4.9. Operation of the setup was confirmed by applying an input DC 
voltage (5 V) and measured output using an oscillosope. The results showed a successful 
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Figure 4.8: Photo of the custom designed multiplexing testing electronic board. The 
counter controls switching rate of the multiplexer. The reset can initiate the switching 
























Figure 4.10: Sensors are sequentially addressed every second
 
In biofilm growth experiments, four chips were operat d in parallel with 4 minutes 
switching time which is sufficient to monitor biofilm changes. 
The biofilm growth area is designed as 
generation of SAWs with a specific wavelength (12 µm)
electric field for the bioelectric effect is imposed by additional electrodes along with the 
biofilm active area. Evaluation of tot
biofilm active area. Therefore, there is a need to confine biofilm growth on the area to 
investigate the device performance. A microfluidic b ofilm reactor was assembled on the 
chip to achieve the restricte
widely used for biological applications since the microchannel can provide more precise 
environment control over a macroscale setup as well as small volume requirement
fabrication of the chan
microfabrication methods. Typically the channel fabricated by PDMS can be disposable 




1.2 mm length by 1 mm width to optimize 
27. The biofilm treatment by an 
al biomass changes in the chip is confined to the 
d biofilm growth. Microfluidic biofilm reactors have been 






To have sufficient area for reversible boning between the PDMS microchannel and the 
chip, the overall dimension of the device was designed as 2.5 cm width by 2.5 cm length. 
The bonding was achieved by methanol30. The PDMS was soaked in methanol for 2 
minutes and place on the chip overnight. Due to the methanol evaporation through the 
PDMS, reversible bonding was achieved based on Van der Waals forces. Through the 
channel, fresh growth media or antibiotics were continuously supplied by a syringe pump 






Figure 4.11: (a) Photo of the fabricated device. Electric pads are extended to have an 
effective contact with external instruments (e.g. network analyzer, power source). (b) 




4.4 Experimental Procedures 
 Luria Broth (LB) bacterial growth media has become an industrial standard for E. 
coli cultivation far back in 1950’s and it is the most common media used in molecular 
microbiology applications. Biofilm growth in the microfluidic channel with the integrated 
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fostered biofilm growth that resulted in increase of total biomass.. LB media is mainly 
composed of yeast, NaCl, and amino acids. Amino acids, such as tryptophan, are the 
source for the protein synthesis needed for bacterial g owth. NaCl produces an osmotic 
pressure balance of the bacteria in the media. Therefore, LB media provided favorable 
environment for E. coli as well as P. aeruginosa biofilm growth166.   To prepare bacteria 
for the biofilm tests, a 20 µL frozen culture of E. coli K12 W3110 (wild type) was 
transferred into 5 mL of LB media in a cell culture tube. Then, the bacteria were cultured 
overnight in the 250 rpm shake incubator at 37 °C for 16 hours. The optical density 
(OD600) was measured after the overnight culture growth, and the OD was typically in the 
4.20 - 4.50 range.  1 mL of the overnight cultured bacteria was diluted 20 times by adding 
LB media to achieve the initial bacterial concentration to be OD600 ≈ 0.21 - 0.23. For 
Pseudomona aeruginosa PAO1, a standard strain of the bacteria, preparation procedures 
are identical to the processes of E. coli. 
Testing is performed by initially disinfecting the microfluidic channels of the 
integrated chip using 70 % ethyl alcohol under flow by the syringe pump. After rinsing 
with deionized water, bacterial suspensions, prepared s above, are inoculated without 
flow for 2 hours to allow for bacterial attachment to the substrate30. LB media is then 
continuously supplied to the channel for 24 hours at 20 µL/h, an effective flow velocity 
of 30 µm/s for the given channel dimensions (100 µm height, 2 mm width, and 2 cm 
length), to replenish nutrients and foster biofilm growth. Treatments are started after 24 
hours of growth and continued for an additional 24 hours. To achieve an exchange of 
fluid sources during experiments with minimal disturbance, flow is stopped and the inlet 
tubing is transferred to the new source of media before reinitializing flow.   
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After biofilm growth, diverse treatment methods including control (no treatment), 
electric field only, bioelectric effect and antibiotic therapies were applied. Finally, at the 
end of the experiments, the total biofilm was quantified by a traditional method, such as a 
live/dead biofilm staining. During the entire biofilm experiments, the SAW sensor 






1. Promote bacterial adhesion 
on the channel 
Supply bacterial suspension for two 
hours (no flow) 
2. Biofilm growth 
Provide bacterial growth media for 24 
hours  
3. Biofilm treatment 
Introduce difference treatments (no 
treatment, antibiotic, electric field and 
bioelectric effect for 24 hours) 
4. Biofilm evaluation Stain biofilm with live/dead dyes 
5. Microscopy imaging work Fluorescent microscope inspection 









4.5 Characterization of the Integrated System 
4.5.1   Detection Limit of the SAW Sensor 
 Prior to biofilm tests, the mass detection limit of the SAW sensor was 
characterized. The SAW sensor sensitivity (frequency changes per unit mass; [Hz/g]) of 
the integrated device was characterized by measuring a resonant frequency shift due to a 
known mass loading. Based on the resolution of the SAW sensor resonant frequency 
measurement equipment (network analyzer, 0.1 Hz resolution), the detection limit [g] 














The known mass was loaded on the SAW propagating area of the sensor between input 
and output IDTs by filling the microfluidic channel with DI water (207 µg). The 
frequency changes were recorded by the network analyzer (HP8510B). Depending on the 
thickness of the passivation layer, different frequncy shifts due to the initial mass 
loading by the passivation layer were expected. As the passivation thickness was 
increased, the detection limit of the sensor was decreased since more initial mass loading 
due to the thicker film reduced the mass sensitivity. The Al2O3 film layer was deposited 
55 nm, 100 nm and 110 nm to prevent ZnO damages from the long term growth media 






Sensor #1 Sensor #2 Sensor #3 Sensor #4 
ZnO ~ 500 nm ~ 500 nm ~ 500 nm ~ 500 nm 
Al 2O3 55 nm 100 nm 100 nm 110 nm 
∆f 1.22 MHz 271 KHz 341 KHz 125 KHz 
Detection 
Limit 17 pg 76 pg 61 pg 166 pg 
Table 4.3: Summary of the SAW sensor characterization 
 
The detection limit characterized by experiments wa decreased from 17 pg to 166 pg as 
the thickness of Al2O3 film was increased from 55 nm to 110 nm. This is expected since 
the passivation film causes attenuation of acoustic wave propagation as well as energy 
loss from the ZnO to the Al2O3 film where biofilms are actually grown. This energy loss 
is due to the mechanical property mismatch including shear modulus and density. As a 
result, minimum detectable mass by the sensor was approximately in tens or hundreds 
pico-gram ranges that are 6 orders decrease of the sensitivity compared to the state of art 
SAW sensor72. However, this is still applicable sensitivity for biofilm detection 
considering a bacterium mass is ~ 1 pg27 and biofilms are comprised of typically more 





Since the SAW sensor is required to have a passivation film to prevent ZnO 
degradation due to the growth media contact, the sensitivity loss compared to the non-
passivated sensor was taken as a trade-off between a highly sensitive sensor and reliable 
operation of the system. Theoretical work to analyze the loss of detection limit was 
conducted concentrated on the effect of different ma erials to the sensitivity loss of the 
system. The analysis was focused on the mechanical acoustic wave energy loss in 
multilayer composition of the structure. Based on the model, a specific material for the 
passivation film was chosen from the candidate material. In the derived equation, 
attenuation of the SAWs was related with the shear modulus, density, thickness of the 
passivation layer on the ZnO.  
The characterization of the sensor was performed on the only Al2O3 passivated 
SAW sensor with different thicknesses of the film. Thus, it may not be appropriate to 
compare the model to the test results (table 1). However, through this comparison, it was 
expected to see the limitations of the current model that would be critical to have further 
sophisticated theory development for future work. To compare the experimental 
characterization results with the model calculation, the raw data was normalized 
respected to the non-passivated SAW sensor and the results from different thickness of 







































Figure 4.12: Normalized sensitivity of the equation (9) in chapter 2 and experimental 
results from table 4.3. The sensitivity was normalized respected to the sensitivity of non
passivated SAW sensor.  
 
As shown in figure 4.12, the results are not exactly matched since there are assumptions 
to simplify the calculations in the model, such as the spee
top regions of the ZnO layer are identical (no disper ion). Intensities of the mechanical 
displacement (acoustic wave) induced at the piezoelctric layer are maximized where the 
electric potential is applied (interdigitated e
of acoustic waves are induced since the piezoelectricity of the film is not a completely 
homogeneous167. The majority of the SAW is determined by the electrode distance of the 
IDT (section 2.1.1). As the acoustic 
from the IDT patterned area, the velocity of partial w ves can be changed due to energy 
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interference among the groups of the SAWs resulting i  dispersion of the wave 
propagation146. This dispersion can be more dominant in the inverted SAW sensor than 
the traditional structure where molecules of interest r act at the IDT patterned surface. 
However, in the model, it was assumed that no dispersion in the ZnO layer can be 
contributed to the calculation error compared to the experimental results. The adhesion 
between the ZnO and passivation film is also assumed to be ideal in the analysis, which 
may not be perfect compared to the single layer film versus multilayer structure.  
The experimental data for the sensitivity was shown to be four times lower than 
the theoretical values. In the modeling, the total effective shear modulus of the 
multilayers of dielectric material on the piezoelectric layer was assumed as a series 
connection to transfer the mechanical energy between th  layers27. However, in real 
energy transfer between the layers, the induced mechani al displacement energy on the 
piezoelectric film by an electrical signal cannot be transferred to the non-piezoelectric 
layer completely as a series connection, since there is significant energy loss or reflection 









Figure 4.14: Experimental data of the normalized sensitivity of the SAW sensor. Its trend 
also approximate to polynomial (2 orders) of relation between the thickness of the 
passivation film and the sensitivity. 
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However, the trend of sensitivity changes of the theoretical and experimental data can be 
closely related as shown in figure 4.13 and 4.14. The orders of magnitude of the trend 
line were approximately in the second order polynomial for both the theoretical and 
experimental results. Considering the purposes of the modeling that was focused on 
investigating the impact of different materials to the sensitivity as well as the applied 
assumptions, this approximation can be validated.  
Typical measured sensitivity of the SAW sensor was in the hundreds of pico-gram 
even for 110 nm passivated sensors. Thisis extremely s nsitive for biofilms, 
(approximately three orders of magnitude) which areusually more than hundreds of 
nano-gram total biomass. With this experimental characterization of the SAW sensor, it 
has been demonstrated that a highly sensitive detection limit for bacterial biofilm 
applications can be achieved. Although the model contributed to select appropriate 
materials as passivation layers among other candidates, the theory can be further 
developed to analyze mechanical energy transfer in multilayer structures that are 




4.6 Biofilm Monitoring of the Integrated System 
4.6.1 Escherichia coli Biofilm 
E. coli (wild type: K-12 W3110) is tested with the integrated system as a model 
biofilm169 (figure 5.8). The bacteria was introduced to the microfluidic channel (100 µm 
height, 2 mm width and 2 cm length) after inoculation of the frozen sample. The increase 
of total biomass was monitored by the SAW sensor based on the speed decrease of the 
wave. The recorded frequency changes are presented in figure 4.15. 
 
Figure 4.15: Schematic of Escherichia coli (Gram negative bacteria)170 
 
The resonant frequency of the sensor decreased by approximately 2 MHz due to the 
significant total mass increase in the biofilm growth after 24 hours. In all experiments, E. 
coli biofilm was established quickly over 10 hours with a continuous supply of fresh 
bacterial growth media. Once biofilms matured, the otal biomass was not changed 
significantly due to the limit of nutrient diffusion into the biofilms. After the biofilms 
were treated by different methods (no treatment, only a tibiotic, only SP field, and SP-
field with the antibiotic), the SP-BE showed approximately a 1.6 MHz resonant 
frequency increase from the start of treatment which corresponds to the reduction of total 
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biomass, while antibiotic or electric field treatment only do not show any frequency 










Figure 4.16: Graph showing the resonant frequency of the SAW sensor tracking the 
changes in biomass due to four different biofilm trea ments initiated after 24 hours of 
biofilm growth. Only the SP-BE demonstrates significant biomass reduction (80% 
reduction of total biomass)32. 
 
Since biofilm treatment typically requires one thousand times more antibiotic than 
treatment of suspended bacteria (~ 5 µg/mL of gentamicin), antibiotic treatment only (10 
µg/mL of gentamicin) administered by itself does not show effective biofilm reduction. 
This is mainly due to the extracellular matrix of biofilms that prevent drug penetration 
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through the matrix. The biofilm treated with electric field only is not effectively inhibited 
since  intensity of the electric signal (0.25 V) lower than the threshold of electrolysis 
(0.82 V) is not sufficient to impose biocidal effects on the biofilm as suggested in 
previous literature112. The SP-BE treatment that combines the SP field with the antibiotic 
demonstrated 80% more biomass reduction than antibiotic treatment alone. This result 
shows the increased biofilm reduction based on the principles of the bioelectric effect. 
The combination of the AC and DC electric field may induce a synergy between AC and 
DC bioelectric effect mechanisms, including increase in permeability of the biofilms due 
to the AC component and non-uniform distribution of electrolytes due to the DC 
component. In addition, it is demonstrated that antibiotics has to be applied 
simultaneously with an electric field to induce enha ced biofilm treatment from the 
comparison between the SP-field and SP-BE results.  
As biofilms are grown, the sensitivity of the SAW sen or also decreases due to the 
additional mass loading compared to the initial  pristine sensor. The non-linearity 
between the mass loading and SAW velocity changes has already been studied (section 
2.1.1). Thus, the frequency changes of the sensor can be directly converted to the biomass 
based on the empirically characterized sensitivity of the system. 
After biofilm experiments are completed, the biofilms were stained by a live/dead 
(green/red) fluorescent dye to visualize viable bacteria in biofilms. Representative images 
of each treatment are shown in figure 4.17. No treatm nt applied biofilm (control) shows 
significant green bacteria in biofilms that correspond to low biofilm treating efficacy. 
Either solely antibiotic or electric field treated biofilms show much more green stained 
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bacterial surface coverage than the SP-BE applied biofilm (figure 4.17d). These results 












                                  SP field (AC + DC fields)                      SP-BE (SP field + 
Gentamicin) 
Figure 4.17: Representative fluorescence microscopy images after different biofilm 
treatment. The green bacteria indicate live cells in biofilm. The SP-BE treated E. coli 
biofilm show significantly reduced live cells in biofilm compared to the traditional 




4.6.2 Pseudomonas aeruginosa Biofilm 
Pseudomonas aeruginosa is one of the major bacterial strains that cause severe 
hospital infections171. P. aeruginosa are categorized as gram negative bacteria that 
comprise double layers of cell membrane. Since bothE. coli and P. aeruginosa are gram 
negative bacteria, cell membrane structures are expcted to be closely related which is 
critical to the principles of activity mode of the bioelectric effect. Either AC or DC 
electric field impacts \ the membrane based on partial charges from the protein and lipid 
bilayer compositions of the cell membrane172.  Based on the previous E. coli biofilm 
treatment demonstration in this thesis work in addition to other literature173, it is expected 
P. aeruginosa biofilm can also be treated by the bioelectric effect.  
 
Figure 4.18: Schematic of Pseudomonas aeruginosa (Gram negative bacteria)174 
 
The experimental procedures are identical to the prvious E. coli biofilm tests. P. 
aeruginosa PAO1 biofilm was matured in the microchannel for 24 hours and followed by 
four different treatments: (1) control (no treatment), (2) only SP field (1.25 V/cm 
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amplitude sinusoidal signal with 1.25 V/cm DC offset), (3) only gentamicin (10 µg/mL) 
and (4) SP-BE (SP field with the gentamicin). The frequency shifts result from the SAW 










Figure 4.19: Changes of the resonant frequency of the SAW sensor in P. aeruginosa 
biofilm experiments. The results also showed signifcant biofilm reduction by the SP-BE 
compared to the other treatments.  
 
As shown in the results, the P. aeruginosa biofilms are established within 20 hours 
during the growth stage. After maturation, the biofilms are in a saturation phase since 
fresh nutrient diffusion is limited by the extracellular matrix of the biofilm. In biofilm 
treatments, significantly reduced biofilms were measured when the SP field was 
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combined with the antibiotics (SP-BE). This result is also in parallel to the previous E.
coli biofilm tests.  
After the experiment, biofilms are stained by the live/dead (green/red) dye and 
investigated by a fluorescent microscope. Representative images of each treatment are 
shown in figure 4.20. The results also support that significant P. aeruginosa biofilm 










                       SP electric field                                        SP-BE (SP field + Gentamicin) 
Figure 4.20: Representative fluorescence microscopy images after four different biofilm 
treatment. The green fluorescence indicates live cells in biofilm. P. aeruginosa biofilm 
treated by the SP-BE shows significantly reduced live cells in biofilm compared to the 




The integrated system of the SAW sensor and bioelectric effect successfully 
demonstrated the biofilm detection and treatment in both E. coli and P. aeruginosa 
biofilm experiments. Two different strains of biofilm are expected to induce enhanced 
biofilm treatment efficacy by the bioelectric effect based on the membrane structure of 
bacteria (gram negative bacteria)175 and literature152. Since the established hypothesis for 
the mechanisms of bioelectric effect is focused on bacterial cell membrane effect by 
external electric field applications112, the same membrane structure between P. 
aeruginosa and E. coli was a critical substance to expect significant biofilm reduction due 
to the bioelectric effect. The membrane is comprised of double layer of phospholipid 
bilayer as shown in figure 5.14. There are a lot of partial charges in the membrane that 
can be distorted by an external electrostatic force. With this induced bacterial membrane 
attenuation due to the electric field, biofilm treatment efficacy can be dramatically 
enhanced with small doses of antibiotics176. Comprehensive studies with diverse strains 
of bacteria have been conducted in the literature65 and demonstrated enhanced biofilm 
reduction when electric fields were applied with antibiotics simultaneously65. Therefore, 
results from this integrated system also correspond t  the suggested mechanisms of the 













Figure 4.21: Schematic of gram negative bacteria. It shows double layers of membrane 
opposed to gram positive bacteria which have only a single layer of cell membrane. Both 
E. coli and P. aeruginosa bacteria are categorized in the gram negative bacteri 177.  
 
In the SAW sensor results of two bacterial biofilms, the improved efficacy of the 
biofilm reduction was closely correlated in terms of t tal biomass changes. In E. coli 
experiments, 80% reduction of biofilm was approximately observed compared to other 
treatments.   P. aeruginosa biofilm similarly showed 70% total biofilm decrease. Since 
the noise level of the resonant frequency monitoring was not able to distinguish within 1% 
level of biomass changes, it was not appropriate to analyze the biofilm differences in 
detail. These noise effects mainly originated from the setup which can contribute to 
include non-uniform distribution of nutrients178, electric interference between the samples 
due to the proximity of each sample179, possible inadequate electric contact via spring 
loaded pins and slight thermal local non-uniformity in the growth chamber180. For more 
sophisticated investigations of biofilm changes, electrical isolation between external 
power supply and each device is necessary although the current setup is able to detect the 
biofilm changes successfully.  
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The device was reused typically five times in consecutive biofilm experiments based 
on the ZnO film passivation by the ALD Al2O3 film. A 500 nm of ZnO layer was 
completely dissolved within 3 hours without the Al2O3 film coating due to the high 
chemical reactivity of the Zn compared to the hydrogen ion (see section 2.1.3). ALD 
provided a conformal and high density film compared to other physical vapor deposition 
methods including sputtering and evaporation. Thus, the ALD was an enabling 
technology to protect the piezoelectric ZnO layer from the growth media diffusion. This 
effective passivation resulted in significantly extended life time of the device from three 
hours to about a week. However, after the chip has been used more than five times , the 
ZnO layer was still damaged due to extended growth media exposure. The surface of the 
sensor was inspected via an optical microscope (figure 4.22) that showed ZnO damage.  
 
 
Figure 4.22: Optical microscopy image of the ZnO layer after five times of consecutive 
biofilm growth experiments. ZnO layer was damaged due to the growth media exposure 







Figure 4.23: Profile of the ZnO damaged surface aftr five times consecutive uses of the 
device for biofilms. The depth of surface damaged points (arrows indicates damaged 
surface) are around 400 nm which is close to the ZnO thickness.  
 
The surface profile of the damaged ZnO layer was investigated using a contact profiler 
(Veeco Dektak 6M Surface Profiler) as shown in figure 5.16. The depth of surface 
damaged area is close to the thickness of the ZnO (500 nm) that indicates bacterial 
growth media penetrated into the ZnO through the Al2O3 film. Once the piezoelectric 
layer is degraded, acoustic waves cannot be induced resulting in failure of biomass 
detection. Even if the single ALD Al2O3 film improved the device life time significantly, 
the reliable operation of the device can be further prolonged using multilayer thin film 
deposition181. For instance, multilayer thin film fabrication by ALD for gas diffusion 
barrier was demonstrated182. However, the sensitivity degradation due to the multilayer of 
dielectric films should be investigated via sophisticated numerical models as well as 






4.7 Summary  
The sensing component of the system was characterized focused on the detection 
limit with a known mass loading and showed extremely high sensitivity for biofilms 
detections. Quantitative electrolysis analysis when an electric field was applied to  the 
growth media was conducted using a pH indicator. The result concluded that the SP field 
does not induce major electrolysis compared to the thr shold voltage applied samples. 
This result suggests that the potential mechanisms of the enhanced biofilm inhibition due 
to the SP field can be due to the superposisition of the AC and DC methods rather than 
creating electrochemical radical ions by electrolysis.  
The integrated microsystem successfully demonstrated real-time biofilm detection 
as well as effective inhibition. Both E. coli and P. aeruginosa biofilms were tested with 
the system. With matured biofilms, the electric field provided by the planar electrodes 
with small doses of the antibiotic gentamicin showed significant total biomass reduction 
in both bacterial biofilms. The continuous biofilm onitoring was demonstrated by 
measuring resonant frequency shifts of the SAW sensor. At the end of the biofilm 
experiment, biofilms were stained by a live/dead fluorescence dye to confirm the biofilm 
surface coverage reduction through the traditional method. The fluorescence images were 
in good agreement with the resonant frequency results from the device. This systematic 
integration of the biofilm sensor with the treatment method as a single platform will 
advance in managing biofilm associated problems based on the small dimension and low 
electric power consumption. Furthermore, this platform can be applied for fundamental 
chemical and biological research, such as for drug iscovery studies.  
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Chapter 5: Conclusions 
5.1 Summary of Accomplishments 
Biofilms are extremely difficult to eradicate when they are established due to their 
complex structures. As a result, bacterial biofilms cause severe clinical infections. 
Revisional surgery and care cost in excess of $500,00  per patient, amounting to more 
than $2 billion annually in the United States. Therefo e, it is crucial to alert patients at the 
early stage of biofilm growth to prevent maturation into severe biofilm infections. In 
addition, a highly effective non-invasive biofilm treatment method is desirable to prevent 
additional surgeries for the treatment. 
In this dissertation work, a microsystem for effective bacterial biofilm management 
through real time biofilm detection and integrated nhanced treatment method was 
successfully designed, fabricated and demonstrated s a single platform. In the biofilm 
sensor development, a numerical analysis model suggested focusing on the evaluation of 
the sensitivity of the sensor with different passivation films. Through the model, a 
passivation material was selected. The key parameters of the derived equation are density, 
thickness and shear modulus of the passivation material hat can be varied in other similar 
multilayer analysis which involves the elastic modulus. The sensor was shown to have 
highly sensitive and reliable biofilm detection performance. The sensor was reusable 
based on the effective passivation film preparation deposited by the atomic layer 
deposition. Based on these theoretical analysis and f brication process developments to 
extend life time of the device, real time biofilm monitoring was successfully achieved 
which is significant for effective biofilm managements.  
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Since biofilm treatment typically requires 500-5000 times of antibiotics, an enhanced 
biofilm treatment method has been developed in a traditional millimeter-scale cuvette 
setup and transferred the new technology into a micro-s ale device as parts of the thesis 
work. Vastly improved treatment of biofilms was demonstrated by employing a 
superpositioned (SP) electric field in conjunction with an antibiotic. The SP bioelectric 
effect (SP-BE) was greater than the sum of the bioelectric effects of the DC and AC 
fields independently. Thus, it is suggested that the SP field enables a synergistic effect 
that yields more bacteriocidal activity when both DC and AC fields are applied. This 
newly developed method can be highlighted that the int nsity of the SP electric field 
utilized here was well below the electrolysis potential of the biological fluid. Hence, we 
envision applications of this technique that would minimize generating harmful radicals 
due to media electrolysis. Perhaps most importantly, these findings suggest that this 
method is aptly suited for deployment in clinical applications.  
Finally, the biofilm sensor and bioelectric treatment were successfully integrated as a 
single platform via microfabrication technologies. Integration of the biofilm detection 
with effective treatment is crucial to realize effective managements of biofilm infections 
through bidirectional biofilm information exchanges from the sensor and treatment. As 
the sensing component provides the early detection of biofilm growth, the biofilm 
treatment via the SP-BE can be more effective before establishing their structures. In 
addition, when biofilms are treated by the bioelectric effect, this integrated chip allows to 
monitor changes of biofilms in real time without requiring additional external bulk 
equipment. The integrated chip was also shown succesful operations with two different 
strains of biofilm (i.e. E. coli and P. aeruginosa). These results suggested that the 
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integrated system can be used for diverse biofilms. The utilization of the system to more 
clinically relevant bacterial biofilms is significant for realizing this device approaches to 
the clinical biofilm infection managements. 
This work can be used as a platform for other biological/clinical fundamental 
researches, such as bacterial metabolism with in different drug treatments and 
investigation of the mechanisms of action of new bacterial treatment methods including 




5.2 Future Work 
The integrated system can be further developed witha wireless system as a signal 
read out as well as operational power supply methods. The SAW sensor requires only 
micro-watts of electrical energy183. In addition, the bioelectric effect is needed to supply 
nano-watt of electrical energy which can be delivered by a traditional radio-frequency 
(RF) inductive coupling184. A RF coil can be microfabricated with a specific resonant 
frequency185. The coil will be tuned to maximize the electric energy coupling for the 
SAW sensor from an external power supply. This wireless system development is critical 
to realize a non-invasive biofilm management and significantly advance point of care and 
further implantable microsystem developments based on the batteryless operation.  
Investigation of the life time of the system in an in-vivo environment is required 
future work toward an implantable system development. Considering variable conditions 
of in-vivo fluidic, such as pH, temperature, compositi ns of electrolytes, immune 
reaction from the host and water concentration or viscosity of blood, the passivation film 
characterization during extensive blood or serum exposure is required. Based on the 
studies in in-vivo conditions, new passivation materi l/fabrication techniques including 
multilayers ALD thin films fabrication158, 159 need to be developed for long term reliable 
operations. 
Finally, once the reliability of the device is investigated, animal tests are required to 
study biocompatibilities as well as performance evaluation of the system in in-vivo 
conditions. As the immune system can react with the device including specific and non-
specific responses, biofouling of the implanted system186 can cause massive signal 
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attenuations and challenges of the output readout especially through a wireless interface. 
In addition, broad immune reaction studies with electrolysis effect due to the biofilm 





# Appendix A 
Network analyzer data save program (S11) 
/* 
 *  Include the WINDOWS.H and DECL-32.H files. The standard Windows 
 *  header file, WINDOWS.H, contains definitions used by DECL-32.H and 







#define ARRAYSIZE 100            // Size of read buffer 
 
int  Dev;                        // Device handle 
char ReadBuffer[ARRAYSIZE + 1];  // Read data buffer 
char ErrorMnemonic[21][5] = {"EDVR", "ECIC", "ENOL", "EADR", "EARG", 
                             "ESAC", "EABO", "ENEB", "EDMA" , "" , 
                             "EOIP", "ECAP", "EFSO", "" , "EBUS", 
                             "ESTB", "ESRQ", "" , "" , "" , "ETAB"}; 
 
 
void GPIBCleanup(int Dev, char* ErrorMsg); 
 
 















 *  Assign a unique identifier to the device and store in the variable 
 *  Dev.  If the ERR bit is set in ibsta, call GPIBCleanup with an 
 *  error message. Otherwise, the device handle, Dev is returned and 




#define BDINDEX               0     // Board Index 
#define PRIMARY_ADDR_OF_DMM   16     // Primary address of device 
#define NO_SECONDARY_ADDR     0     // Secondary address of device 
#define TIMEOUT               T10s  // Timeout value = 10 seconds 
#define EOTMODE               1     // Enable the END message 
#define EOSMODE               0     // Disable the EOS mode 
 
    Dev = ibdev (BDINDEX, PRIMARY_ADDR_OF_DMM, 
NO_SECONDARY_ADDR, 
                TIMEOUT, EOTMODE, EOSMODE); 
    if  (ibsta & ERR) 
    { 
       GPIBCleanup(Dev, "Unable to open device"); 
       return 1; 
    } 
 
/* 
 *  Clear the internal or device functions of the device.  If the error 
 *  bit ERR is set in ibsta, call GPIBCleanup with an error message. 
 */ 
 
    ibclr (Dev); 
    if  (ibsta & ERR) 
    { 
       GPIBCleanup(Dev, "Unable to clear device"); 
       return 1; 







 *  MAIN BODY SECTION 
 * 
 *  In this application, the Main Body communicates with the instrument 
 *  by writing a command to it and reading its response. This would be 










 *  Request the identification code by sending the instruction '*IDN?'. 
 *  If the error bit ERR is set in ibsta, call GPIBCleanup with an error 





 ibwrt (Dev, "MARKMINI;OUTPACTI" , 17L); 
    if  (ibsta & ERR) 
    { 
       GPIBCleanup(Dev, "Unable to write to device"); 
       return 1; 
    } 
 
/* 
 *  Read the identification code by calling ibrd. If the ERR bit is 
 *  set in ibsta, call GPIBCleanup with an error message. 
 */ 
 
    ibrd (Dev, ReadBuffer, ARRAYSIZE); 
    if  (ibsta & ERR) 
    { 
       GPIBCleanup(Dev, "Unable to read data from device"); 
       return 1; 
    } 
 
/* 
 *  Assume that the returned string contains ASCII data. NULL terminate 
 *  the string using the value in ibcntl which is the number of bytes 
 *  read in. Use printf to display the string. 
 */ 
/* time example */ 
 
     
    ReadBuffer[ibcntl] = '\0'; 
    printf("Returned string:  %s\n", ReadBuffer); 
  
 //Create a file to write to 
    FILE *OutFile = fopen("S21freq.txt","a"); 
    //Send data to file 
    fprintf(OutFile,"%s\n",ReadBuffer); 
    //Close the file  
    fclose(OutFile); 
 
ibwrt (Dev, "OUTPMARK;MARKMINI" , 17L); 
    if  (ibsta & ERR) 
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    { 
       GPIBCleanup(Dev, "Unable to write to device"); 
       return 1; 
    } 
 
/* 
 *  Read the identification code by calling ibrd. If the ERR bit is 
 *  set in ibsta, call GPIBCleanup with an error message. 
 */ 
 
    ibrd (Dev, ReadBuffer, ARRAYSIZE); 
    if  (ibsta & ERR) 
    { 
       GPIBCleanup(Dev, "Unable to read data from device"); 
       return 1; 
    } 
 
/* 
 *  Assume that the returned string contains ASCII data. NULL terminate 
 *  the string using the value in ibcntl which is the number of bytes 
 *  read in. Use printf to display the string. 
 */ 
 
    ReadBuffer[ibcntl] = '\0'; 
    printf("Returned string:  %s\n", ReadBuffer); 
  
 //Create a file to write to 
    FILE *OutFile1 = fopen("S11intensity.txt","a"); 
    //Send data to file 
    fprintf(OutFile1,"%s\n",ReadBuffer); 
    //Close the file  

















/*  Take the device offline.                                           */ 
 
    ibonl (Dev, 0); 
 






 *  After each GPIB call, the application checks whether the call 
 *  succeeded. If an NI-488.2 call fails, the GPIB driver sets the 
 *  corresponding bit in the global status variable. If the call 
 *  failed, this procedure prints an error message, takes the 
 *  device offline and exits. 
 */ 
void GPIBCleanup(int ud, char* ErrorMsg) 
{ 
    printf("Error : %s\nibsta = 0x%x iberr = %d (%s)\n", 
            ErrorMsg, ibsta, iberr, ErrorMnemonic[iberr]); 
    if  (ud != -1) 
    { 
       printf("Cleanup: Taking device offline\n"); 
       ibonl (ud, 0); 






























Network analyzer data save program (S21) 
/* 
 *  Include the WINDOWS.H and DECL-32.H files. The standard Windows 
 *  header file, WINDOWS.H, contains definitions used by DECL-32.H and 







#define ARRAYSIZE 100            // Size of read buffer 
 
int  Dev;                        // Device handle 
char ReadBuffer[ARRAYSIZE + 1];  // Read data buffer 
char ErrorMnemonic[21][5] = {"EDVR", "ECIC", "ENOL", "EADR", "EARG", 
                             "ESAC", "EABO", "ENEB", "EDMA" , "" , 
                             "EOIP", "ECAP", "EFSO", "" , "EBUS", 
                             "ESTB", "ESRQ", "" , "" , "" , "ETAB"}; 
 
 
void GPIBCleanup(int Dev, char* ErrorMsg); 
 
 

















 *  Assign a unique identifier to the device and store in the variable 
 *  Dev.  If the ERR bit is set in ibsta, call GPIBCleanup with an 
 *  error message. Otherwise, the device handle, Dev is returned and 
 *  is used in all subsequent calls to the device. 
 */ 
#define BDINDEX               0     // Board Index 
#define PRIMARY_ADDR_OF_DMM   16     // Primary address of device 
#define NO_SECONDARY_ADDR     0     // Secondary address of device 
#define TIMEOUT               T10s  // Timeout value = 10 seconds 
#define EOTMODE               1     // Enable the END message 
#define EOSMODE               0     // Disable the EOS mode 
 
    Dev = ibdev (BDINDEX, PRIMARY_ADDR_OF_DMM, 
NO_SECONDARY_ADDR, 
                TIMEOUT, EOTMODE, EOSMODE); 
    if  (ibsta & ERR) 
    { 
       GPIBCleanup(Dev, "Unable to open device"); 
       return 1; 
    } 
 
/* 
 *  Clear the internal or device functions of the device.  If the error 
 *  bit ERR is set in ibsta, call GPIBCleanup with an error message. 
 */ 
 
    ibclr (Dev); 
    if  (ibsta & ERR) 
    { 
       GPIBCleanup(Dev, "Unable to clear device"); 
       return 1; 







 *  MAIN BODY SECTION 
 * 
 *  In this application, the Main Body communicates with the instrument 
 *  by writing a command to it and reading its response. This would be 










 *  Request the identification code by sending the instruction '*IDN?'. 
 *  If the error bit ERR is set in ibsta, call GPIBCleanup with an error 





 ibwrt (Dev, "MARKMAXI;OUTPACTI" , 17L); 
    if  (ibsta & ERR) 
    { 
       GPIBCleanup(Dev, "Unable to write to device"); 
       return 1; 
    } 
 
/* 
 *  Read the identification code by calling ibrd. If the ERR bit is 
 *  set in ibsta, call GPIBCleanup with an error message. 
 */ 
 
    ibrd (Dev, ReadBuffer, ARRAYSIZE); 
    if  (ibsta & ERR) 
    { 
       GPIBCleanup(Dev, "Unable to read data from device"); 
       return 1; 
    } 
 
/* 
 *  Assume that the returned string contains ASCII data. NULL terminate 
 *  the string using the value in ibcntl which is the number of bytes 
 *  read in. Use printf to display the string. 
 */ 
/* time example */ 
 
     
    ReadBuffer[ibcntl] = '\0'; 
    printf("Returned string:  %s\n", ReadBuffer); 
  
 //Create a file to write to 
    FILE *OutFile = fopen("S21freq.txt","a"); 
    //Send data to file 
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    fprintf(OutFile,"%s\n",ReadBuffer); 
    //Close the file  
    fclose(OutFile); 
 
ibwrt (Dev, "OUTPMARK;MARKMAXI" , 17L); 
    if  (ibsta & ERR) 
    { 
       GPIBCleanup(Dev, "Unable to write to device"); 
       return 1; 
    } 
 
/* 
 *  Read the identification code by calling ibrd. If the ERR bit is 
 *  set in ibsta, call GPIBCleanup with an error message. 
 */ 
 
    ibrd (Dev, ReadBuffer, ARRAYSIZE); 
    if  (ibsta & ERR) 
    { 
       GPIBCleanup(Dev, "Unable to read data from device"); 
       return 1; 
    } 
 
/* 
 *  Assume that the returned string contains ASCII data. NULL terminate 
 *  the string using the value in ibcntl which is the number of bytes 
 *  read in. Use printf to display the string. 
 */ 
 
    ReadBuffer[ibcntl] = '\0'; 
    printf("Returned string:  %s\n", ReadBuffer); 
  
 //Create a file to write to 
    FILE *OutFile1 = fopen("S21intensity.txt","a"); 
    //Send data to file 
    fprintf(OutFile1,"%s\n",ReadBuffer); 
    //Close the file  

















/*  Take the device offline.                                           */ 
 
    ibonl (Dev, 0); 
 






 *  After each GPIB call, the application checks whether the call 
 *  succeeded. If an NI-488.2 call fails, the GPIB driver sets the 
 *  corresponding bit in the global status variable. If the call 
 *  failed, this procedure prints an error message, takes the 
 *  device offline and exits. 
 */ 
void GPIBCleanup(int ud, char* ErrorMsg) 
{ 
    printf("Error : %s\nibsta = 0x%x iberr = %d (%s)\n", 
            ErrorMsg, ibsta, iberr, ErrorMnemonic[iberr]); 
    if  (ud != -1) 
    { 
       printf("Cleanup: Taking device offline\n"); 
       ibonl (ud, 0); 














Appendix B: MATLAB Code for Data Analysis  
Data filtering program  
% Data smooth filter program 
% final plot is time vs negative frequency shift 
  
a = 1; % constant for filtering function 
m = 3; % number of average points, you can change it. 
b=zeros(1,m); 
for l=1:1:m 
    b(1,l)=1/m; 
end 
  
% raw data % 
x=[      
  









   X2(n,1)=X(n+m-1,1); 





T=t*16/60;   % time [hour] 
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